{"data": [{"id": "2ztuy", "type": "registrations", "attributes": {"title": "Experiences with Parents and Well-being in College", "description": "", "category": "project", "custom_citation": "", "date_created": "2020-03-16T01:21:32.199575", "date_modified": "2020-02-28T13:53:51.767951", "registration": true, "preprint": false, "fork": false, "collection": false, "tags": [], "access_requests_enabled": false, "node_license": null, "analytics_key": "897a2418fef174878c3c52a9a8fc49768fa0d91f529d6650b339a74e6e41ca1beed130b2739bbd3352c38b0d486f6027e11297a486c8fccb10829a123139e2001f4b5082d8a1f99642925c64c7204cdf0b18a1753ae6d2d03c6497a1de11d8ebd1d7ebe965fc0a6165a2c74115753146cead92497e454d5eec94330a7fe2aab46c9853208b875ddec699f04d11e674e6", "current_user_can_comment": false, "current_user_permissions": ["read"], "current_user_is_contributor": false, "current_user_is_contributor_or_group_member": false, "wiki_enabled": true, "public": true, "article_doi": null, "pending_embargo_approval": false, "pending_embargo_termination_approval": false, "embargoed": false, "pending_registration_approval": false, "archiving": false, "pending_withdrawal": false, "withdrawn": false, "date_registered": "2020-03-16T01:21:32.182058", "date_withdrawn": null, "embargo_end_date": null, "withdrawal_justification": null, "registration_supplement": "OSF Preregistration", "registered_meta": {"q1": {"extra": [], "value": "Experiences with Parents and Well-being in College"}, "q2": {"extra": [], "value": "Guadalupe Torres"}, "q3": {"extra": [], "value": "Though there is research in collectivistic and individualistic cultures concerning family values, this study unpacks the research to examine parenting qualities of the parent-child relationship and the effects on the college student. This study will examine the relationship between family\nobligation values and well-being outcomes (e.g. self-esteem and mood). "}, "q4": {"extra": [], "value": "             Family obligation and psychological well-being is moderated by (depends on) students\u2019 culture, defined by cultural group membership (Hypothesis 1a) and cultural values (Hypothesis 1b; e.g., simpatia and harmony values). We predict overall group differences in cultural group differences. \n                 Parenting qualities would moderate the relationship between family obligation and psychosocial well-being outcomes (Hypothesis 2).\n                  Hypothesis 2a: For higher parental warmth, the relationship between family obligation and better psychosocial well-being outcomes is strengthened for Latinx and Euro American students, but is null for Asian American students. \n                Hypothesis 2b: For higher parental support, the relationship between family obligation and better psychosocial well-being outcomes strengthens for all groups.\n                Hypothesis 2c: For higher parental investments, the relationship between family obligation and better psychosocial well-being outcomes strengthens for both Asian American and Latinx students, but is null for Euro American students.\n          As an exploratory research question, we also explored whether or not parent gender ( for the parenting quality) differentiated the moderating effect between family obligation and psychosocial well-being outcomes."}, "q5": {"extra": [], "value": "Observational Study - Data is collected from study subjects that are not randomly assigned to a treatment. This includes surveys, \u201cnatural experiments,\u201d and regression discontinuity designs."}, "q6": {"extra": [], "value": ["No blinding is involved in this study."]}, "q7": {"extra": [], "value": "N/A"}, "q8": {"value": {"question": {"extra": [], "value": "This is a cross-sectional correlational survey study "}, "uploader": {"extra": [], "value": ""}}}, "q9": {"extra": [], "value": "N/A"}, "q10": {"extra": [], "value": "Registration prior to any human observation of the data"}, "q11": {"extra": [], "value": "Data collection began last week but it will not be analyzed until the end of data collection. "}, "q12": {"value": {"question": {"extra": [], "value": "We will recruit participants that self-identify as European American ( 3rd gen and beyond), Asian American ( 1st or 2nd gen) and Latinx (1st or 2nd gen) through affinity group emails, social media advertisements, and Haverford College's introductory psych 100 human subject pool (SONA).  They must be at least 18 years of age and over to participate in the study. Participants who are completing this study for their introductory psychology class will receive 0.5 research credits. The other participants will receive a $5 e-gift card of their choice to either Amazon.com OR Starbucks."}, "uploader": {"extra": [], "value": ""}}}, "q13": {"extra": [], "value": "We will recruit 40-50 Euro Americans, 40-50 Asian Americans, and 40-50 Latinx for a total sample ranging between 120 and 150 participants."}, "q14": {"extra": [], "value": ""}, "q15": {"extra": [], "value": ""}, "q16": {"value": {"question": {"extra": [], "value": "N/A"}, "uploader": {"extra": [], "value": ""}}}, "q17": {"value": {"question": {"extra": [], "value": "The 18-item Attitudinal Familism measure was used to assess college students\u2019 attitudes on familism. The scale scored items on a 10-point Likert-type scale ranging from 1 (strongly disagree) to 10 (strongly agree). \n\nThe Harmony Values Scale was comprised of two subscales to assess college students\u2019 harmony values. The two were Emotion Harmony\u201d (e.g., \u201cIt is better to hold one\u2019s emotions inside than to burden others by expressing them\u201d) and \u201cSocial Harmony\u201d (e.g., \u201cEven when I strongly disagree with someone close to me, I avoid an argument\u201d). Subjects were scored items from 1 (strongly disagree) to 10 (strongly agree). \n\nSimpatia was measured using the 9-item BFI Agreeableness scale on the Big Five measures from 1 ( strongly disagree) to 10 ( strongly agree).\n\nFamily Obligation Scale consists of three subscales:  (a) current assistance to the family , (b) respect for the family, and (c) future support to the family. We measured the first subscale by asking participants \u201cHow often do you think you should do the following things?\u201d on a 5-point Likert scale ranging from 1 ( almost never) to 5 ( Almost Always). We measured \u201crespect for family\u201d by asking them \u201cIn general, how important is it to you that you...\u201d on a 5-point scale.The third, last subscale \u201cfuture support\u201d was asked \u201cHow important is it to you that in the future you...\u201d and measured on the same 5-point Likert scale as \u201crespect for family\u201d.\n\nThe Multidimensional Scale for Perceived Social Support scale was used to assess college students\u2019 perceived parental support from each individual parent. We measured them together  prompting them with this:  \u201cI want you to think about your relationship with your parent(s) and how each statement fits the way your parent(s) treats you.\u201d Subjects were scored items from 1( Almost Never True) - 4 (Almost Always True).\n\nParental warmth was measured using the PARQ subscale for warmth/affection. We measured parental warmth prompting them with: \u201cI want you to think about your relationship with your parent(s) and how each statement fits the way your parent(s) treats you.\u201d They were then ask to each answer the way they  perceive their \nrespective parent(s) really are rather than the way you might want to from a scale of 1 (Almost Never True) to  4(Almost Always True). \n\nPerceived parental sacrifices was used to assess their perceptions of their parents\u2019 sacrifices for the 23-item scale with components (striving for family resources, time spent on children\u2019s education, restructuring of daily routine, sacrifice of lifestyles and aspirations, shielding of worries) rated from 1 (strongly disagree) to 4 (strongly agree). \n\nSelf-Esteem was measured using the Rosenberg Self-Esteem Scale, which is a 10-item scale with a 7- point rating scale from 1 (strongly disagree) to 4 ( strongly agree).\n\nDepressive symptoms were measured using 10-item form of the Center for Epidemiologic Studies Depression Scale. Participants rated each item using a 4-point Likert scale from \u201c0\u201d (none of the time) to \u201c3\u201d (most or all of the time). \n"}, "uploader": {"extra": [], "value": ""}}}, "q18": {"value": {"question": {"extra": [], "value": ""}, "uploader": {"extra": [], "value": ""}}}, "q19": {"value": {"question": {"extra": [], "value": "Moderated multiple regression to test for main hypotheses; we will use ANOVA for cultural group differences."}, "uploader": {"extra": [], "value": ""}}}, "q20": {"extra": [], "value": ""}, "q21": {"extra": [], "value": ""}, "q22": {"extra": [], "value": ""}, "q23": {"extra": [], "value": ""}, "q24": {"extra": [], "value": ""}, "q25": {"extra": [], "value": ""}}, "registration_responses": {"q1": "Experiences with Parents and Well-being in College", "q2": "Guadalupe Torres", "q3": "Though there is research in collectivistic and individualistic cultures concerning family values, this study unpacks the research to examine parenting qualities of the parent-child relationship and the effects on the college student. This study will examine the relationship between family\nobligation values and well-being outcomes (e.g. self-esteem and mood). ", "q4": "             Family obligation and psychological well-being is moderated by (depends on) students\u2019 culture, defined by cultural group membership (Hypothesis 1a) and cultural values (Hypothesis 1b; e.g., simpatia and harmony values). We predict overall group differences in cultural group differences. \n                 Parenting qualities would moderate the relationship between family obligation and psychosocial well-being outcomes (Hypothesis 2).\n                  Hypothesis 2a: For higher parental warmth, the relationship between family obligation and better psychosocial well-being outcomes is strengthened for Latinx and Euro American students, but is null for Asian American students. \n                Hypothesis 2b: For higher parental support, the relationship between family obligation and better psychosocial well-being outcomes strengthens for all groups.\n                Hypothesis 2c: For higher parental investments, the relationship between family obligation and better psychosocial well-being outcomes strengthens for both Asian American and Latinx students, but is null for Euro American students.\n          As an exploratory research question, we also explored whether or not parent gender ( for the parenting quality) differentiated the moderating effect between family obligation and psychosocial well-being outcomes.", "q5": "Observational Study - Data is collected from study subjects that are not randomly assigned to a treatment. This includes surveys, \u201cnatural experiments,\u201d and regression discontinuity designs.", "q6": ["No blinding is involved in this study."], "q7": "N/A", "q9": "N/A", "q10": "Registration prior to any human observation of the data", "q11": "Data collection began last week but it will not be analyzed until the end of data collection. ", "q13": "We will recruit 40-50 Euro Americans, 40-50 Asian Americans, and 40-50 Latinx for a total sample ranging between 120 and 150 participants.", "q14": "", "q15": "", "q20": "", "q21": "", "q22": "", "q23": "", "q24": "", "q25": "", "q8.question": "This is a cross-sectional correlational survey study ", "q8.uploader": [], "q12.question": "We will recruit participants that self-identify as European American ( 3rd gen and beyond), Asian American ( 1st or 2nd gen) and Latinx (1st or 2nd gen) through affinity group emails, social media advertisements, and Haverford College's introductory psych 100 human subject pool (SONA).  They must be at least 18 years of age and over to participate in the study. Participants who are completing this study for their introductory psychology class will receive 0.5 research credits. The other participants will receive a $5 e-gift card of their choice to either Amazon.com OR Starbucks.", "q12.uploader": [], "q16.question": "N/A", "q16.uploader": [], "q17.question": "The 18-item Attitudinal Familism measure was used to assess college students\u2019 attitudes on familism. The scale scored items on a 10-point Likert-type scale ranging from 1 (strongly disagree) to 10 (strongly agree). \n\nThe Harmony Values Scale was comprised of two subscales to assess college students\u2019 harmony values. The two were Emotion Harmony\u201d (e.g., \u201cIt is better to hold one\u2019s emotions inside than to burden others by expressing them\u201d) and \u201cSocial Harmony\u201d (e.g., \u201cEven when I strongly disagree with someone close to me, I avoid an argument\u201d). Subjects were scored items from 1 (strongly disagree) to 10 (strongly agree). \n\nSimpatia was measured using the 9-item BFI Agreeableness scale on the Big Five measures from 1 ( strongly disagree) to 10 ( strongly agree).\n\nFamily Obligation Scale consists of three subscales:  (a) current assistance to the family , (b) respect for the family, and (c) future support to the family. We measured the first subscale by asking participants \u201cHow often do you think you should do the following things?\u201d on a 5-point Likert scale ranging from 1 ( almost never) to 5 ( Almost Always). We measured \u201crespect for family\u201d by asking them \u201cIn general, how important is it to you that you...\u201d on a 5-point scale.The third, last subscale \u201cfuture support\u201d was asked \u201cHow important is it to you that in the future you...\u201d and measured on the same 5-point Likert scale as \u201crespect for family\u201d.\n\nThe Multidimensional Scale for Perceived Social Support scale was used to assess college students\u2019 perceived parental support from each individual parent. We measured them together  prompting them with this:  \u201cI want you to think about your relationship with your parent(s) and how each statement fits the way your parent(s) treats you.\u201d Subjects were scored items from 1( Almost Never True) - 4 (Almost Always True).\n\nParental warmth was measured using the PARQ subscale for warmth/affection. We measured parental warmth prompting them with: \u201cI want you to think about your relationship with your parent(s) and how each statement fits the way your parent(s) treats you.\u201d They were then ask to each answer the way they  perceive their \nrespective parent(s) really are rather than the way you might want to from a scale of 1 (Almost Never True) to  4(Almost Always True). \n\nPerceived parental sacrifices was used to assess their perceptions of their parents\u2019 sacrifices for the 23-item scale with components (striving for family resources, time spent on children\u2019s education, restructuring of daily routine, sacrifice of lifestyles and aspirations, shielding of worries) rated from 1 (strongly disagree) to 4 (strongly agree). \n\nSelf-Esteem was measured using the Rosenberg Self-Esteem Scale, which is a 10-item scale with a 7- point rating scale from 1 (strongly disagree) to 4 ( strongly agree).\n\nDepressive symptoms were measured using 10-item form of the Center for Epidemiologic Studies Depression Scale. Participants rated each item using a 4-point Likert scale from \u201c0\u201d (none of the time) to \u201c3\u201d (most or all of the time). \n", "q17.uploader": [], "q18.question": "", "q18.uploader": [], "q19.question": "Moderated multiple regression to test for main hypotheses; we will use ANOVA for cultural group differences.", "q19.uploader": []}, "subjects": []}, "relationships": {"children": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/2ztuy/children/?format=json", "meta": {}}}}, "comments": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/2ztuy/comments/?format=json&filter%5Btarget%5D=2ztuy", "meta": {}}}}, "contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/2ztuy/contributors/?format=json", "meta": {}}}}, "bibliographic_contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/2ztuy/bibliographic_contributors/?format=json", "meta": {}}}}, "implicit_contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/2ztuy/implicit_contributors/?format=json", "meta": {}}}}, "files": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/2ztuy/files/?format=json", "meta": {}}}}, "wikis": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/2ztuy/wikis/?format=json", "meta": {}}}}, "forks": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/2ztuy/forks/?format=json", "meta": {}}}}, "node_links": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/2ztuy/node_links/?format=json", "meta": {}}}}, "linked_by_nodes": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/2ztuy/linked_by_nodes/?format=json", "meta": {}}}}, "linked_by_registrations": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/2ztuy/linked_by_registrations/?format=json", "meta": {}}}}, "identifiers": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/2ztuy/identifiers/?format=json", "meta": {}}}}, "affiliated_institutions": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/2ztuy/institutions/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/2ztuy/relationships/institutions/?format=json", "meta": {}}}}, "region": {"links": {"related": {"href": "https://api.osf.io/v2/regions/us/?format=json", "meta": {}}}, "data": {"id": "us", "type": "regions"}}, "root": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/2ztuy/?format=json", "meta": {}}}, "data": {"id": "2ztuy", "type": "registrations"}}, "logs": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/2ztuy/logs/?format=json", "meta": {}}}}, "linked_nodes": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/2ztuy/linked_nodes/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/2ztuy/relationships/linked_nodes/?format=json", "meta": {}}}}, "linked_registrations": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/2ztuy/linked_registrations/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/2ztuy/relationships/linked_registrations/?format=json", "meta": {}}}}, "view_only_links": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/2ztuy/view_only_links/?format=json", "meta": {}}}}, "citation": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/2ztuy/citation/?format=json", "meta": {}}}, "data": {"id": "2ztuy", "type": "registrations"}}, "registered_by": {"links": {"related": {"href": "https://api.osf.io/v2/users/xjq93/?format=json", "meta": {}}}, "data": {"id": "xjq93", "type": "users"}}, "registered_from": {"links": {"related": {"href": "https://api.osf.io/v2/nodes/ecjzp/?format=json", "meta": {}}}, "data": {"id": "ecjzp", "type": "nodes"}}, "registration_schema": {"links": {"related": {"href": "https://api.osf.io/v2/schemas/registrations/5c08457ed283380029cf73bf/?format=json", "meta": {}}}, "data": {"id": "5c08457ed283380029cf73bf", "type": "registration-schemas"}}, "provider": {"links": {"related": {"href": "https://api.osf.io/v2/providers/registrations/osf/?format=json", "meta": {}}}}}, "links": {"html": "https://osf.io/2ztuy/", "self": "https://api.osf.io/v2/registrations/2ztuy/"}}, {"id": "7fqwa", "type": "registrations", "attributes": {"title": "Uso de datos de la vida real sobre enfermedades cr\u00f3nicas no transmisibles para la toma de decisiones en salud: revisi\u00f3n sistem\u00e1tica de la literatura producida en M\u00e9xico", "description": "", "category": "project", "custom_citation": "", "date_created": "2020-03-20T17:50:33.135779", "date_modified": "2020-04-20T20:12:51.880047", "registration": true, "preprint": false, "fork": false, "collection": false, "tags": [], "access_requests_enabled": false, "node_license": null, "analytics_key": "b2ee00e7cf850ce888745ad36685cbde0cef0ca9fa93d7628e8f2128b2331da72593c4918c3191a73c41d110c64d2a6613f9f8162cf593b23b089707c0bbd5c8aeaec65c11d798ce6825b0ccfe314c3086bb116de3e087254f4edc73b65304e2bf5c7c6b0ed1fda22a571ac1288fa8310d9af76099b31589536535a3faf3debb10bda53d4eed54a7cb3ab2d6b5a3d2d7", "current_user_can_comment": false, "current_user_permissions": ["read"], "current_user_is_contributor": false, "current_user_is_contributor_or_group_member": false, "wiki_enabled": true, "public": true, "article_doi": null, "pending_embargo_approval": false, "pending_embargo_termination_approval": false, "embargoed": false, "pending_registration_approval": false, "archiving": false, "pending_withdrawal": false, "withdrawn": false, "date_registered": "2020-03-20T17:50:33.117294", "date_withdrawn": null, "embargo_end_date": null, "withdrawal_justification": null, "registration_supplement": "Open-Ended Registration", "registered_meta": {"summary": {"extra": [], "value": "Objetivo: evaluar los estudios publicados a partir datos de la vida real para mejorar la pr\u00e1ctica cl\u00ednica, la calidad de vida de los pacientes y la utilizaci\u00f3n adecuada de f\u00e1rmacos en las enfermedades cr\u00f3nicas no transmisibles (ECNT) en M\u00e9xico. \nMaterial y m\u00e9todos: revisi\u00f3n sistem\u00e1tica de literatura acorde a las pautas propuestas en el Manual Cochrane para Revisiones Sistem\u00e1ticas de Intervenciones. \nResultados: del a\u00f1o 2009 al 2018, se encontraron 9 estudios no aleatorizados en M\u00e9xico que utilizan datos de la vida real para abordar la pr\u00e1ctica cl\u00ednica, la calidad de vida de los pacientes y la utilizaci\u00f3n adecuada de f\u00e1rmacos en las ECNT. \nConclusiones: El uso de datos de la vida real para estudiar las ECNT para la pr\u00e1ctica cl\u00ednica, calidad de vida y la utilizaci\u00f3n de f\u00e1rmacos es un tema en auge en M\u00e9xico y en el mundo, pero son tendencia para mejorar la calidad de la atenci\u00f3n m\u00e9dica y la toma de decisiones en salud."}, "uploader": {"extra": [], "value": ""}}, "registration_responses": {"summary": "Objetivo: evaluar los estudios publicados a partir datos de la vida real para mejorar la pr\u00e1ctica cl\u00ednica, la calidad de vida de los pacientes y la utilizaci\u00f3n adecuada de f\u00e1rmacos en las enfermedades cr\u00f3nicas no transmisibles (ECNT) en M\u00e9xico. \nMaterial y m\u00e9todos: revisi\u00f3n sistem\u00e1tica de literatura acorde a las pautas propuestas en el Manual Cochrane para Revisiones Sistem\u00e1ticas de Intervenciones. \nResultados: del a\u00f1o 2009 al 2018, se encontraron 9 estudios no aleatorizados en M\u00e9xico que utilizan datos de la vida real para abordar la pr\u00e1ctica cl\u00ednica, la calidad de vida de los pacientes y la utilizaci\u00f3n adecuada de f\u00e1rmacos en las ECNT. \nConclusiones: El uso de datos de la vida real para estudiar las ECNT para la pr\u00e1ctica cl\u00ednica, calidad de vida y la utilizaci\u00f3n de f\u00e1rmacos es un tema en auge en M\u00e9xico y en el mundo, pero son tendencia para mejorar la calidad de la atenci\u00f3n m\u00e9dica y la toma de decisiones en salud.", "uploader": []}, "subjects": []}, "relationships": {"children": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/7fqwa/children/?format=json", "meta": {}}}}, "comments": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/7fqwa/comments/?format=json&filter%5Btarget%5D=7fqwa", "meta": {}}}}, "contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/7fqwa/contributors/?format=json", "meta": {}}}}, "bibliographic_contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/7fqwa/bibliographic_contributors/?format=json", "meta": {}}}}, "implicit_contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/7fqwa/implicit_contributors/?format=json", "meta": {}}}}, "files": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/7fqwa/files/?format=json", "meta": {}}}}, "wikis": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/7fqwa/wikis/?format=json", "meta": {}}}}, "forks": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/7fqwa/forks/?format=json", "meta": {}}}}, "node_links": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/7fqwa/node_links/?format=json", "meta": {}}}}, "linked_by_nodes": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/7fqwa/linked_by_nodes/?format=json", "meta": {}}}}, "linked_by_registrations": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/7fqwa/linked_by_registrations/?format=json", "meta": {}}}}, "identifiers": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/7fqwa/identifiers/?format=json", "meta": {}}}}, "affiliated_institutions": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/7fqwa/institutions/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/7fqwa/relationships/institutions/?format=json", "meta": {}}}}, "region": {"links": {"related": {"href": "https://api.osf.io/v2/regions/us/?format=json", "meta": {}}}, "data": {"id": "us", "type": "regions"}}, "root": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/7fqwa/?format=json", "meta": {}}}, "data": {"id": "7fqwa", "type": "registrations"}}, "logs": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/7fqwa/logs/?format=json", "meta": {}}}}, "linked_nodes": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/7fqwa/linked_nodes/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/7fqwa/relationships/linked_nodes/?format=json", "meta": {}}}}, "linked_registrations": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/7fqwa/linked_registrations/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/7fqwa/relationships/linked_registrations/?format=json", "meta": {}}}}, "view_only_links": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/7fqwa/view_only_links/?format=json", "meta": {}}}}, "citation": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/7fqwa/citation/?format=json", "meta": {}}}, "data": {"id": "7fqwa", "type": "registrations"}}, "registered_by": {"links": {"related": {"href": "https://api.osf.io/v2/users/sbgw8/?format=json", "meta": {}}}, "data": {"id": "sbgw8", "type": "users"}}, "registered_from": {"links": {"related": {"href": "https://api.osf.io/v2/nodes/bsd8y/?format=json", "meta": {}}}, "data": {"id": "bsd8y", "type": "nodes"}}, "registration_schema": {"links": {"related": {"href": "https://api.osf.io/v2/schemas/registrations/5df83f7dd28338001ac0ab0d/?format=json", "meta": {}}}, "data": {"id": "5df83f7dd28338001ac0ab0d", "type": "registration-schemas"}}, "provider": {"links": {"related": {"href": "https://api.osf.io/v2/providers/registrations/osf/?format=json", "meta": {}}}}}, "links": {"html": "https://osf.io/7fqwa/", "self": "https://api.osf.io/v2/registrations/7fqwa/"}}, {"id": "n5amc", "type": "registrations", "attributes": {"title": "Protocolo de investigaci\u00f3n.  Uso de datos de la vida real sobre enfermedades cr\u00f3nicas no transmisibles para la toma de decisiones en salud: Revisi\u00f3n sistem\u00e1tica de la literatura producida en M\u00e9xico", "description": "", "category": "project", "custom_citation": "", "date_created": "2020-03-20T17:29:43.612373", "date_modified": "2020-04-20T20:09:49.913160", "registration": true, "preprint": false, "fork": false, "collection": false, "tags": [], "access_requests_enabled": false, "node_license": null, "analytics_key": "e8949908e40db93b46234f20ace964463679a94bfbcd4925c4fe64a0b24c402cea116ea58fd30a0a6f5a3eef79b601bbe2f07ad86ca4eee70f221d1712a5c20e91156ffc0839d2b6d2d75ad3e4e317fa682c23337b43e2595ec1778202e99fc1615f24505cf9c4b52423392bb5700c3f899fe5c92a73ef16b0a5b4d8a02d1aa183830787dae6c178fd5578115ada05a0", "current_user_can_comment": false, "current_user_permissions": ["read"], "current_user_is_contributor": false, "current_user_is_contributor_or_group_member": false, "wiki_enabled": true, "public": true, "article_doi": null, "pending_embargo_approval": false, "pending_embargo_termination_approval": false, "embargoed": false, "pending_registration_approval": false, "archiving": false, "pending_withdrawal": false, "withdrawn": false, "date_registered": "2020-03-20T17:29:43.569547", "date_withdrawn": null, "embargo_end_date": null, "withdrawal_justification": null, "registration_supplement": "Open-Ended Registration", "registered_meta": {"summary": {"extra": [], "value": "Objetivo: evaluar los estudios publicados con datos de la vida real para mejorar la pr\u00e1ctica cl\u00ednica, la calidad de vida de los pacientes y la utilizaci\u00f3n adecuada de f\u00e1rmacos en las Enfermedades Cr\u00f3nicas No Transmisibles (ECNT) en M\u00e9xico. \nMaterial y m\u00e9todos: revisi\u00f3n sistem\u00e1tica de literatura acorde a las pautas propuestas en el Manual Cochrane para Revisiones Sistem\u00e1ticas de Intervenciones. \nResultados esperados: identificar los alcances de la evidencia cient\u00edfica producida en M\u00e9xico con datos de la vida real y los aspectos que pueden mejorar para fortalecer la atenci\u00f3n de las ECNT dentro del sistema de salud."}, "uploader": {"extra": [{"data": {"name": "Aprobaci\u00f3n \u00c9tica.pdf"}, "nodeId": "fujkc", "sha256": "4e38c876702ae78030791597f7c4d39341db4e2d752b93ef4855700fad0b59cb", "viewUrl": "/project/n5amc/files/osfstorage/5e74fd8e4a60a50577bb0fc7/", "selectedFileName": "Aprobaci\u00f3n \u00c9tica.pdf"}, {"data": {"name": "Aprobaci\u00f3n Bioseguridad.pdf"}, "nodeId": "fujkc", "sha256": "e00ec96b93a18d41db5440ba3a03982947afd0d1faab04029c84a352392f631d", "viewUrl": "/project/n5amc/files/osfstorage/5e74fd8d4a60a50577bb0fc5/", "selectedFileName": "Aprobaci\u00f3n Bioseguridad.pdf"}, {"data": {"name": "Aprobaci\u00f3n Investigaci\u00f3n.pdf"}, "nodeId": "fujkc", "sha256": "c4a60617c9a41dc18d4c30f49cfcddc7c7d40d26985eadb13a9590920af225e1", "viewUrl": "/project/n5amc/files/osfstorage/5e74fd8d4a60a50577bb0fc3/", "selectedFileName": "Aprobaci\u00f3n Investigaci\u00f3n.pdf"}, {"data": {"name": "Protocolo RWD_FnLeo.pdf"}, "nodeId": "fujkc", "sha256": "257fe77296fe6673bca186480842ab297430383846fe0f251728e09a699c5d0d", "viewUrl": "/project/n5amc/files/osfstorage/5e74fd8d4a60a50577bb0fc1/", "selectedFileName": "Protocolo RWD_FnLeo.pdf"}], "value": ""}}, "registration_responses": {"summary": "Objetivo: evaluar los estudios publicados con datos de la vida real para mejorar la pr\u00e1ctica cl\u00ednica, la calidad de vida de los pacientes y la utilizaci\u00f3n adecuada de f\u00e1rmacos en las Enfermedades Cr\u00f3nicas No Transmisibles (ECNT) en M\u00e9xico. \nMaterial y m\u00e9todos: revisi\u00f3n sistem\u00e1tica de literatura acorde a las pautas propuestas en el Manual Cochrane para Revisiones Sistem\u00e1ticas de Intervenciones. \nResultados esperados: identificar los alcances de la evidencia cient\u00edfica producida en M\u00e9xico con datos de la vida real y los aspectos que pueden mejorar para fortalecer la atenci\u00f3n de las ECNT dentro del sistema de salud.", "uploader": [{"file_id": "5e74fd8e4a60a50577bb0fc7", "file_name": "Aprobaci\u00f3n \u00c9tica.pdf", "file_urls": {"html": "https://osf.io/project/n5amc/files/osfstorage/5e74fd8e4a60a50577bb0fc7", "download": "https://osf.io/download/5e74fd8e4a60a50577bb0fc7"}, "file_hashes": {"sha256": "4e38c876702ae78030791597f7c4d39341db4e2d752b93ef4855700fad0b59cb"}}, {"file_id": "5e74fd8d4a60a50577bb0fc5", "file_name": "Aprobaci\u00f3n Bioseguridad.pdf", "file_urls": {"html": "https://osf.io/project/n5amc/files/osfstorage/5e74fd8d4a60a50577bb0fc5", "download": "https://osf.io/download/5e74fd8d4a60a50577bb0fc5"}, "file_hashes": {"sha256": "e00ec96b93a18d41db5440ba3a03982947afd0d1faab04029c84a352392f631d"}}, {"file_id": "5e74fd8d4a60a50577bb0fc3", "file_name": "Aprobaci\u00f3n Investigaci\u00f3n.pdf", "file_urls": {"html": "https://osf.io/project/n5amc/files/osfstorage/5e74fd8d4a60a50577bb0fc3", "download": "https://osf.io/download/5e74fd8d4a60a50577bb0fc3"}, "file_hashes": {"sha256": "c4a60617c9a41dc18d4c30f49cfcddc7c7d40d26985eadb13a9590920af225e1"}}, {"file_id": "5e74fd8d4a60a50577bb0fc1", "file_name": "Protocolo RWD_FnLeo.pdf", "file_urls": {"html": "https://osf.io/project/n5amc/files/osfstorage/5e74fd8d4a60a50577bb0fc1", "download": "https://osf.io/download/5e74fd8d4a60a50577bb0fc1"}, "file_hashes": {"sha256": "257fe77296fe6673bca186480842ab297430383846fe0f251728e09a699c5d0d"}}]}, "subjects": []}, "relationships": {"children": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n5amc/children/?format=json", "meta": {}}}}, "comments": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n5amc/comments/?format=json&filter%5Btarget%5D=n5amc", "meta": {}}}}, "contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n5amc/contributors/?format=json", "meta": {}}}}, "bibliographic_contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n5amc/bibliographic_contributors/?format=json", "meta": {}}}}, "implicit_contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n5amc/implicit_contributors/?format=json", "meta": {}}}}, "files": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n5amc/files/?format=json", "meta": {}}}}, "wikis": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n5amc/wikis/?format=json", "meta": {}}}}, "forks": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n5amc/forks/?format=json", "meta": {}}}}, "node_links": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n5amc/node_links/?format=json", "meta": {}}}}, "linked_by_nodes": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n5amc/linked_by_nodes/?format=json", "meta": {}}}}, "linked_by_registrations": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n5amc/linked_by_registrations/?format=json", "meta": {}}}}, "identifiers": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n5amc/identifiers/?format=json", "meta": {}}}}, "affiliated_institutions": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n5amc/institutions/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/n5amc/relationships/institutions/?format=json", "meta": {}}}}, "region": {"links": {"related": {"href": "https://api.osf.io/v2/regions/us/?format=json", "meta": {}}}, "data": {"id": "us", "type": "regions"}}, "root": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n5amc/?format=json", "meta": {}}}, "data": {"id": "n5amc", "type": "registrations"}}, "logs": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n5amc/logs/?format=json", "meta": {}}}}, "linked_nodes": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n5amc/linked_nodes/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/n5amc/relationships/linked_nodes/?format=json", "meta": {}}}}, "linked_registrations": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n5amc/linked_registrations/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/n5amc/relationships/linked_registrations/?format=json", "meta": {}}}}, "view_only_links": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n5amc/view_only_links/?format=json", "meta": {}}}}, "citation": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n5amc/citation/?format=json", "meta": {}}}, "data": {"id": "n5amc", "type": "registrations"}}, "registered_by": {"links": {"related": {"href": "https://api.osf.io/v2/users/sbgw8/?format=json", "meta": {}}}, "data": {"id": "sbgw8", "type": "users"}}, "registered_from": {"links": {"related": {"href": "https://api.osf.io/v2/nodes/fujkc/?format=json", "meta": {}}}, "data": {"id": "fujkc", "type": "nodes"}}, "registration_schema": {"links": {"related": {"href": "https://api.osf.io/v2/schemas/registrations/5df83f7dd28338001ac0ab0d/?format=json", "meta": {}}}, "data": {"id": "5df83f7dd28338001ac0ab0d", "type": "registration-schemas"}}, "provider": {"links": {"related": {"href": "https://api.osf.io/v2/providers/registrations/osf/?format=json", "meta": {}}}}}, "links": {"html": "https://osf.io/n5amc/", "self": "https://api.osf.io/v2/registrations/n5amc/"}}, {"id": "d36x8", "type": "registrations", "attributes": {"title": "Mapping population mental health concerns related to COVID-19 and the consequences of physical distancing: a Google trends analysis", "description": "The 2020 Coronavirus pandemic is a major international public health challenge.  Governments have taken public health protection measures to reduce the spread of the virus through non-pharamlogocial measures. The impact of the pandemic and the public health response on individual and population mental health is unknown.   Methods: We used Google Trends data (1 Jan 2020 - 1 Apr 2020) to investigate the impact of the pandemic and government measures to curb it on people\u2019s concerns, as indexed by changes in search frequency for topics indicating mental distress, social and economic stressors and mental health treatment-seeking.", "category": "data", "custom_citation": "", "date_created": "2020-04-20T18:29:58.180004", "date_modified": "2020-04-20T19:39:14.889950", "registration": true, "preprint": false, "fork": false, "collection": false, "tags": [], "access_requests_enabled": false, "node_license": {"copyright_holders": [], "year": null}, "analytics_key": "022ccfd1af38ddc847c80da2a1b004b95e21f772ed010107d153eb3b8e8cf93de0459b7c5bb470c21894b832e4dc130812536422751ee5a5429316357eee872c112248667511645c82eabcc3f0e0dd64b4ba71c67ed860901368782b06886f67c0180caef593dfe1b47c91cb24c54ca3b7074a8fdfc93944626ec50f2bb377bd4d5261ff1f6f90c61db8c59a953adfc1", "current_user_can_comment": false, "current_user_permissions": ["read"], "current_user_is_contributor": false, "current_user_is_contributor_or_group_member": false, "wiki_enabled": true, "public": true, "article_doi": null, "pending_embargo_approval": false, "pending_embargo_termination_approval": false, "embargoed": false, "pending_registration_approval": false, "archiving": false, "pending_withdrawal": false, "withdrawn": false, "date_registered": "2020-04-20T18:29:58.151301", "date_withdrawn": null, "embargo_end_date": null, "withdrawal_justification": null, "registration_supplement": "Open-Ended Registration", "registered_meta": {"summary": {"extra": [], "value": "Raw data files associated with publication"}, "uploader": {"extra": [{"data": {"name": "coviddata2020mainFINAL.xls"}, "nodeId": "pxgte", "sha256": "f50cb7e3ee3d18a0e06924d3bc1b82a586e84d351ec06c1e4b01017a867ad4d3", "viewUrl": "/project/pxgte/files/osfstorage/5e98504ff13535051dd5564d", "selectedFileName": "coviddata2020mainFINAL.xls"}, {"data": {"name": "coviddatamainFINAL.xls"}, "nodeId": "pxgte", "sha256": "5830f838bb17d50942b629889c7c468ae022ff4ed0af4657e81c23d1b0f1c8e0", "viewUrl": "/project/pxgte/files/osfstorage/5e9db8d1f1353506e0d525ad", "selectedFileName": "coviddatamainFINAL.xls"}], "value": ""}}, "registration_responses": {"summary": "Raw data files associated with publication", "uploader": [{"file_id": "5e98504ff13535051dd5564d", "file_name": "coviddata2020mainFINAL.xls", "file_urls": {"html": "https://osf.io/pxgte/files/osfstorage/5e98504ff13535051dd5564d", "download": "https://osf.io/download/5e98504ff13535051dd5564d/"}, "file_hashes": {"sha256": "f50cb7e3ee3d18a0e06924d3bc1b82a586e84d351ec06c1e4b01017a867ad4d3"}}, {"file_id": "5e9db8d1f1353506e0d525ad", "file_name": "coviddatamainFINAL.xls", "file_urls": {"html": "https://osf.io/pxgte/files/osfstorage/5e9db8d1f1353506e0d525ad", "download": "https://osf.io/download/5e9db8d1f1353506e0d525ad/"}, "file_hashes": {"sha256": "5830f838bb17d50942b629889c7c468ae022ff4ed0af4657e81c23d1b0f1c8e0"}}]}, "subjects": [[{"id": "584240da54be81056cecaaaa", "text": "Medicine and Health Sciences"}]]}, "relationships": {"license": {"links": {"related": {"href": "https://api.osf.io/v2/licenses/563c1cf88c5e4a3877f9e96c/?format=json", "meta": {}}}, "data": {"id": "563c1cf88c5e4a3877f9e96c", "type": "licenses"}}, "children": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/d36x8/children/?format=json", "meta": {}}}}, "comments": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/d36x8/comments/?format=json&filter%5Btarget%5D=d36x8", "meta": {}}}}, "contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/d36x8/contributors/?format=json", "meta": {}}}}, "bibliographic_contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/d36x8/bibliographic_contributors/?format=json", "meta": {}}}}, "implicit_contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/d36x8/implicit_contributors/?format=json", "meta": {}}}}, "files": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/d36x8/files/?format=json", "meta": {}}}}, "wikis": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/d36x8/wikis/?format=json", "meta": {}}}}, "forks": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/d36x8/forks/?format=json", "meta": {}}}}, "node_links": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/d36x8/node_links/?format=json", "meta": {}}}}, "linked_by_nodes": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/d36x8/linked_by_nodes/?format=json", "meta": {}}}}, "linked_by_registrations": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/d36x8/linked_by_registrations/?format=json", "meta": {}}}}, "identifiers": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/d36x8/identifiers/?format=json", "meta": {}}}}, "affiliated_institutions": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/d36x8/institutions/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/d36x8/relationships/institutions/?format=json", "meta": {}}}}, "region": {"links": {"related": {"href": "https://api.osf.io/v2/regions/de-1/?format=json", "meta": {}}}, "data": {"id": "de-1", "type": "regions"}}, "root": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/d36x8/?format=json", "meta": {}}}, "data": {"id": "d36x8", "type": "registrations"}}, "logs": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/d36x8/logs/?format=json", "meta": {}}}}, "linked_nodes": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/d36x8/linked_nodes/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/d36x8/relationships/linked_nodes/?format=json", "meta": {}}}}, "linked_registrations": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/d36x8/linked_registrations/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/d36x8/relationships/linked_registrations/?format=json", "meta": {}}}}, "view_only_links": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/d36x8/view_only_links/?format=json", "meta": {}}}}, "citation": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/d36x8/citation/?format=json", "meta": {}}}, "data": {"id": "d36x8", "type": "registrations"}}, "registered_by": {"links": {"related": {"href": "https://api.osf.io/v2/users/5u8bm/?format=json", "meta": {}}}, "data": {"id": "5u8bm", "type": "users"}}, "registered_from": {"links": {"related": {"href": "https://api.osf.io/v2/nodes/pxgte/?format=json", "meta": {}}}, "data": {"id": "pxgte", "type": "nodes"}}, "registration_schema": {"links": {"related": {"href": "https://api.osf.io/v2/schemas/registrations/5df83f7dd28338001ac0ab0d/?format=json", "meta": {}}}, "data": {"id": "5df83f7dd28338001ac0ab0d", "type": "registration-schemas"}}, "provider": {"links": {"related": {"href": "https://api.osf.io/v2/providers/registrations/osf/?format=json", "meta": {}}}}}, "links": {"html": "https://osf.io/d36x8/", "self": "https://api.osf.io/v2/registrations/d36x8/"}}, {"id": "cf639", "type": "registrations", "attributes": {"title": "Screening Asymptomatic Persons for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)", "description": "To assess the accuracy and effectiveness of different screening strategies for SARS-CoV-2 in populations without known COVID-19 disease. ", "category": "project", "custom_citation": "", "date_created": "2020-04-08T15:59:42.913323", "date_modified": "2020-04-08T15:52:15.330726", "registration": true, "preprint": false, "fork": false, "collection": false, "tags": ["coronavirus", "covid19"], "access_requests_enabled": false, "node_license": {"copyright_holders": ["Viswanathan M", "Gartlehner G", "Kahwati L", "Jahn B", "Giger K", "Dobrescu AI", "Klerings I", "Hill C", "Meixner J", "Persad E", "Teufer B"], "year": "2020"}, "analytics_key": "dc06dce6442a93de42d5bed7f6a1c4387b3290b6d734d9b0867b246e099263d66d45151eb75b6254cf552c3dc8f5ce523d75f5a396aa43c449e4f970d48ed4c0a1d6f788b19b67df1e0445e8534191f539b1d271bc94dedde2f66ebd4556b449fab995d05bdbf5e3342ce047f1e76e13f2a7461e816d9e67b6f8e770ea96b2d128c751ba6997607f9512b188afd876c7", "current_user_can_comment": false, "current_user_permissions": ["read"], "current_user_is_contributor": false, "current_user_is_contributor_or_group_member": false, "wiki_enabled": true, "public": true, "article_doi": null, "pending_embargo_approval": false, "pending_embargo_termination_approval": false, "embargoed": false, "pending_registration_approval": false, "archiving": false, "pending_withdrawal": false, "withdrawn": false, "date_registered": "2020-04-08T15:59:42.888428", "date_withdrawn": null, "embargo_end_date": null, "withdrawal_justification": null, "registration_supplement": "OSF Preregistration", "registered_meta": {"q1": {"extra": [], "value": "Emma Persad, Gerald Gartlehner, Meera Viswanathan, Andreea Dobrescu, Birgit Teufer, Irma Klerings, Jana Meixner, Christine Hill, Kayla Giger, Leila Kahwati, Beate Jahn"}, "q2": {"extra": [], "value": "The purpose of screening and benefits of screening in asymptomatic persons may change as the pandemic progresses. In the early stages of the spread of the virus in a given location, screening seeks to identify infected but asymptomatic persons with a high degree of accuracy. This may help with containment strategies. \nWhen containment is no longer possible because of widespread community transmission or when test supplies are limited, screening of the general population may not alter the trajectory of the pandemic, but screening of asymptomatic healthcare workers may help support the healthcare system by both identifying positive cases and negative cases with a high degree of accuracy. \nScreening may be relevant for containment in subsequent rounds of community transmission after initial containment in a community; in these instances, screening requires the identification of infected persons with a high degree of accuracy. \nAfter sustained community transmission, screening of asymptomatic persons may also be relevant for supporting re-entry of those who have been infected with SARS-CoV-2 (with or without symptoms) into the workforce, schools, and community. Screening that identifies infected persons with a high degree of accuracy can support re-entry; this assumes that screening will reliably identify antibodies, that those exposed have immunity, and that the virus does not mutate significantly. In these cases, screening also requires the identification of persons without prior infection with a high degree of accuracy, to shield them from potential exposure. \n"}, "q3": {"extra": [], "value": "Meta-Analysis - A systematic review of published studies."}, "q4": {"extra": [], "value": ["No blinding is involved in this study."]}, "q5": {"extra": [], "value": ""}, "q6": {"value": {"question": {"extra": [], "value": "Systematic review comprising: \n\u2612 RCTs\n\u2612 Quasi-RCTs \n\u2612 Non-randomised controlled trials\n\u2612 Prospective cohort studies\n\u2612 Retrospective cohort studies\n\u2612 Case-control studies\n\u2612 Cross-sectional studies\n\u2612 Controlled before-and-after studies\n\u2612 Modelling studies\n\u2612 Other (please specify) Any design with data on screening accuracy\n"}, "uploader": {"extra": [{"data": {"name": "covid-19_rr_protocol_screening_accuracy_effectiveness_Apr_6_2020.pdf"}, "nodeId": "q6pza", "sha256": "81435bb47317fd497c7c44a7577e583058aa57d91893b8956a3ea17574ef1520", "viewUrl": "/project/cf639/files/osfstorage/5e8df4f3d6973501b7bdb6b6/", "selectedFileName": "covid-19_rr_protocol_screening_accuracy_effectiveness_Apr_6_2020.pdf"}], "value": ""}}}, "q7": {"extra": [], "value": ""}, "q8": {"extra": [], "value": "Registration prior to accessing the data"}, "q9": {"extra": [], "value": ""}, "q10": {"value": {"question": {"extra": [], "value": "The searches will be informed by a content expert, conducted by an information specialist (IK), and independently peer reviewed. \n\nElectronic databases will be searched from 12/1/2019 until 4/20/2020: \n\u2612 MEDLINE \n\u2612 CENTRAL\n\u2612 EMBASE\n\u2612 Other: LitCovid, CDC COVID-19 Research Database (https://www.cdc.gov/library/researchguides/2019novelcoronavirus/researcharticles.html), Cochrane Covid 19 Register; \n\nAdditional searches will be made here: \n\u2612 Systematic review references\n\u2612 Reference lists of included studies\n\u2612 Grey literature (please specify)\n\u2612 Other: China National Knowledge Infrastructure; Chinese Journal of Epidemiology; Chinese Journal of Preventive Medicine; Chinese Journal of Infectious Diseases \n\nPICO eligibility: \n\nPopulation: \nGeneral populations without known SARS-CoV-2 infection\nSpecial populations of interest are healthcare workers without known SARS-CoV-2 infection\nStudies focusing only on diagnostic testing among persons with presumptive COVID-19 symptoms or known exposure to SARS-CoV-2 (except for healthcare workers) will be excluded.\nStudies with a subset of relevant participants will be included if more than 80% meet inclusion criteria \n\nIntervention: \n1.\tFor the accuracy key question: clinical risk assessment (e.g., fever, dry cough, shortness of breath, gastrointestinal symptoms, loss of smell or taste), epidemiological risk assessment (history of travel from hot spots, contact with persons known or suspected of having SARS-CoV-2 infection), body temperature checks, feasible point-of-care laboratory tests (e.g., rapid PCR test, rapid immunoassays, CRISPR), or a combination of these approaches\n2.\tFor the effectiveness key question: screening using the above approaches across the entire population or selected segments of the population based on occupation, geographic setting, or community characteristics \n\nComparison: \n1.\tFor the accuracy key question: confirmatory diagnostic tests (reverse-transcription polymerase chain reaction (RT-PCR) or antibody immunoassay tests, clustered regularly interspaced short palindromic repeats (CRISPR), or a combination of these approaches)\n2.\tFor the effectiveness key question: no screening, screening in selected populations based on occupation, geographic setting, or community characteristics\n\nOutcomes: \n1.\tFor the accuracy key question: Sensitivity, specificity, positive predictive value, negative predictive value, area under the receiver operating characteristic curve\n2.\tFor the effectiveness key question: incident cases, missed cases, successfully detected cases, reduced transmission, mortality \nStudies will be included in the review irrespective of whether measured outcome data are reported in a \u2018usable\u2019 way.\n\n"}, "uploader": {"extra": [{"data": {"name": "covid-19_rr_protocol_screening_accuracy_effectiveness_Apr_6_2020.pdf"}, "nodeId": "q6pza", "sha256": "81435bb47317fd497c7c44a7577e583058aa57d91893b8956a3ea17574ef1520", "viewUrl": "/project/cf639/files/osfstorage/5e8df4f3d6973501b7bdb6b6/", "selectedFileName": "covid-19_rr_protocol_screening_accuracy_effectiveness_Apr_6_2020.pdf"}], "value": ""}}}, "q11": {"extra": [], "value": "N/A"}, "q12": {"extra": [], "value": ""}, "q13": {"extra": [], "value": ""}, "q14": {"value": {"question": {"extra": [], "value": ""}, "uploader": {"extra": [], "value": ""}}}, "q15": {"value": {"question": {"extra": [], "value": "1.\tFor the accuracy key question: Sensitivity, specificity, positive predictive value, negative predictive value, area under the receiver operating characteristic curve\n2.\tFor the effectiveness key question: incident cases, missed cases, successfully detected cases, reduced transmission, mortality \nStudies will be included in the review irrespective of whether measured outcome data are reported in a \u2018usable\u2019 way.\n"}, "uploader": {"extra": [], "value": ""}}}, "q16": {"value": {"question": {"extra": [], "value": ""}, "uploader": {"extra": [{"data": {"name": "covid-19_rr_protocol_screening_accuracy_effectiveness_Apr_6_2020.pdf"}, "nodeId": "q6pza", "sha256": "81435bb47317fd497c7c44a7577e583058aa57d91893b8956a3ea17574ef1520", "viewUrl": "/project/cf639/files/osfstorage/5e8df4f3d6973501b7bdb6b6/", "selectedFileName": "covid-19_rr_protocol_screening_accuracy_effectiveness_Apr_6_2020.pdf"}], "value": ""}}}, "q17": {"value": {"question": {"extra": [], "value": "N/A"}, "uploader": {"extra": [], "value": ""}}}, "q18": {"extra": [], "value": ""}, "q19": {"extra": [], "value": ""}, "q20": {"extra": [], "value": ""}, "q21": {"extra": [], "value": ""}, "q22": {"extra": [], "value": ""}, "q23": {"extra": [], "value": ""}}, "registration_responses": {"q1": "Emma Persad, Gerald Gartlehner, Meera Viswanathan, Andreea Dobrescu, Birgit Teufer, Irma Klerings, Jana Meixner, Christine Hill, Kayla Giger, Leila Kahwati, Beate Jahn", "q2": "The purpose of screening and benefits of screening in asymptomatic persons may change as the pandemic progresses. In the early stages of the spread of the virus in a given location, screening seeks to identify infected but asymptomatic persons with a high degree of accuracy. This may help with containment strategies. \nWhen containment is no longer possible because of widespread community transmission or when test supplies are limited, screening of the general population may not alter the trajectory of the pandemic, but screening of asymptomatic healthcare workers may help support the healthcare system by both identifying positive cases and negative cases with a high degree of accuracy. \nScreening may be relevant for containment in subsequent rounds of community transmission after initial containment in a community; in these instances, screening requires the identification of infected persons with a high degree of accuracy. \nAfter sustained community transmission, screening of asymptomatic persons may also be relevant for supporting re-entry of those who have been infected with SARS-CoV-2 (with or without symptoms) into the workforce, schools, and community. Screening that identifies infected persons with a high degree of accuracy can support re-entry; this assumes that screening will reliably identify antibodies, that those exposed have immunity, and that the virus does not mutate significantly. In these cases, screening also requires the identification of persons without prior infection with a high degree of accuracy, to shield them from potential exposure. \n", "q3": "Meta-Analysis - A systematic review of published studies.", "q4": ["No blinding is involved in this study."], "q5": "", "q7": "", "q8": "Registration prior to accessing the data", "q9": "", "q11": "N/A", "q12": "", "q13": "", "q18": "", "q19": "", "q20": "", "q21": "", "q22": "", "q23": "", "q6.question": "Systematic review comprising: \n\u2612 RCTs\n\u2612 Quasi-RCTs \n\u2612 Non-randomised controlled trials\n\u2612 Prospective cohort studies\n\u2612 Retrospective cohort studies\n\u2612 Case-control studies\n\u2612 Cross-sectional studies\n\u2612 Controlled before-and-after studies\n\u2612 Modelling studies\n\u2612 Other (please specify) Any design with data on screening accuracy\n", "q6.uploader": [{"file_id": "5e8df4f3d6973501b7bdb6b6", "file_name": "covid-19_rr_protocol_screening_accuracy_effectiveness_Apr_6_2020.pdf", "file_urls": {"html": "https://osf.io/project/cf639/files/osfstorage/5e8df4f3d6973501b7bdb6b6", "download": "https://osf.io/download/5e8df4f3d6973501b7bdb6b6"}, "file_hashes": {"sha256": "81435bb47317fd497c7c44a7577e583058aa57d91893b8956a3ea17574ef1520"}}], "q10.question": "The searches will be informed by a content expert, conducted by an information specialist (IK), and independently peer reviewed. \n\nElectronic databases will be searched from 12/1/2019 until 4/20/2020: \n\u2612 MEDLINE \n\u2612 CENTRAL\n\u2612 EMBASE\n\u2612 Other: LitCovid, CDC COVID-19 Research Database (https://www.cdc.gov/library/researchguides/2019novelcoronavirus/researcharticles.html), Cochrane Covid 19 Register; \n\nAdditional searches will be made here: \n\u2612 Systematic review references\n\u2612 Reference lists of included studies\n\u2612 Grey literature (please specify)\n\u2612 Other: China National Knowledge Infrastructure; Chinese Journal of Epidemiology; Chinese Journal of Preventive Medicine; Chinese Journal of Infectious Diseases \n\nPICO eligibility: \n\nPopulation: \nGeneral populations without known SARS-CoV-2 infection\nSpecial populations of interest are healthcare workers without known SARS-CoV-2 infection\nStudies focusing only on diagnostic testing among persons with presumptive COVID-19 symptoms or known exposure to SARS-CoV-2 (except for healthcare workers) will be excluded.\nStudies with a subset of relevant participants will be included if more than 80% meet inclusion criteria \n\nIntervention: \n1.\tFor the accuracy key question: clinical risk assessment (e.g., fever, dry cough, shortness of breath, gastrointestinal symptoms, loss of smell or taste), epidemiological risk assessment (history of travel from hot spots, contact with persons known or suspected of having SARS-CoV-2 infection), body temperature checks, feasible point-of-care laboratory tests (e.g., rapid PCR test, rapid immunoassays, CRISPR), or a combination of these approaches\n2.\tFor the effectiveness key question: screening using the above approaches across the entire population or selected segments of the population based on occupation, geographic setting, or community characteristics \n\nComparison: \n1.\tFor the accuracy key question: confirmatory diagnostic tests (reverse-transcription polymerase chain reaction (RT-PCR) or antibody immunoassay tests, clustered regularly interspaced short palindromic repeats (CRISPR), or a combination of these approaches)\n2.\tFor the effectiveness key question: no screening, screening in selected populations based on occupation, geographic setting, or community characteristics\n\nOutcomes: \n1.\tFor the accuracy key question: Sensitivity, specificity, positive predictive value, negative predictive value, area under the receiver operating characteristic curve\n2.\tFor the effectiveness key question: incident cases, missed cases, successfully detected cases, reduced transmission, mortality \nStudies will be included in the review irrespective of whether measured outcome data are reported in a \u2018usable\u2019 way.\n\n", "q10.uploader": [{"file_id": "5e8df4f3d6973501b7bdb6b6", "file_name": "covid-19_rr_protocol_screening_accuracy_effectiveness_Apr_6_2020.pdf", "file_urls": {"html": "https://osf.io/project/cf639/files/osfstorage/5e8df4f3d6973501b7bdb6b6", "download": "https://osf.io/download/5e8df4f3d6973501b7bdb6b6"}, "file_hashes": {"sha256": "81435bb47317fd497c7c44a7577e583058aa57d91893b8956a3ea17574ef1520"}}], "q14.question": "", "q14.uploader": [], "q15.question": "1.\tFor the accuracy key question: Sensitivity, specificity, positive predictive value, negative predictive value, area under the receiver operating characteristic curve\n2.\tFor the effectiveness key question: incident cases, missed cases, successfully detected cases, reduced transmission, mortality \nStudies will be included in the review irrespective of whether measured outcome data are reported in a \u2018usable\u2019 way.\n", "q15.uploader": [], "q16.question": "", "q16.uploader": [{"file_id": "5e8df4f3d6973501b7bdb6b6", "file_name": "covid-19_rr_protocol_screening_accuracy_effectiveness_Apr_6_2020.pdf", "file_urls": {"html": "https://osf.io/project/cf639/files/osfstorage/5e8df4f3d6973501b7bdb6b6", "download": "https://osf.io/download/5e8df4f3d6973501b7bdb6b6"}, "file_hashes": {"sha256": "81435bb47317fd497c7c44a7577e583058aa57d91893b8956a3ea17574ef1520"}}], "q17.question": "N/A", "q17.uploader": []}, "subjects": [[{"id": "584240da54be81056cecaaaa", "text": "Medicine and Health Sciences"}], [{"id": "584240da54be81056cecaab0", "text": "Life Sciences"}]]}, "relationships": {"license": {"links": {"related": {"href": "https://api.osf.io/v2/licenses/563c1cf88c5e4a3877f9e965/?format=json", "meta": {}}}, "data": {"id": "563c1cf88c5e4a3877f9e965", "type": "licenses"}}, "children": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/cf639/children/?format=json", "meta": {}}}}, "comments": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/cf639/comments/?format=json&filter%5Btarget%5D=cf639", "meta": {}}}}, "contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/cf639/contributors/?format=json", "meta": {}}}}, "bibliographic_contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/cf639/bibliographic_contributors/?format=json", "meta": {}}}}, "implicit_contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/cf639/implicit_contributors/?format=json", "meta": {}}}}, "files": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/cf639/files/?format=json", "meta": {}}}}, "wikis": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/cf639/wikis/?format=json", "meta": {}}}}, "forks": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/cf639/forks/?format=json", "meta": {}}}}, "node_links": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/cf639/node_links/?format=json", "meta": {}}}}, "linked_by_nodes": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/cf639/linked_by_nodes/?format=json", "meta": {}}}}, "linked_by_registrations": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/cf639/linked_by_registrations/?format=json", "meta": {}}}}, "identifiers": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/cf639/identifiers/?format=json", "meta": {}}}}, "affiliated_institutions": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/cf639/institutions/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/cf639/relationships/institutions/?format=json", "meta": {}}}}, "region": {"links": {"related": {"href": "https://api.osf.io/v2/regions/us/?format=json", "meta": {}}}, "data": {"id": "us", "type": "regions"}}, "root": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/cf639/?format=json", "meta": {}}}, "data": {"id": "cf639", "type": "registrations"}}, "logs": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/cf639/logs/?format=json", "meta": {}}}}, "linked_nodes": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/cf639/linked_nodes/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/cf639/relationships/linked_nodes/?format=json", "meta": {}}}}, "linked_registrations": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/cf639/linked_registrations/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/cf639/relationships/linked_registrations/?format=json", "meta": {}}}}, "view_only_links": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/cf639/view_only_links/?format=json", "meta": {}}}}, "citation": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/cf639/citation/?format=json", "meta": {}}}, "data": {"id": "cf639", "type": "registrations"}}, "registered_by": {"links": {"related": {"href": "https://api.osf.io/v2/users/t3amq/?format=json", "meta": {}}}, "data": {"id": "t3amq", "type": "users"}}, "registered_from": {"links": {"related": {"href": "https://api.osf.io/v2/nodes/q6pza/?format=json", "meta": {}}}, "data": {"id": "q6pza", "type": "nodes"}}, "registration_schema": {"links": {"related": {"href": "https://api.osf.io/v2/schemas/registrations/5e795fc0d2833800195735d0/?format=json", "meta": {}}}, "data": {"id": "5e795fc0d2833800195735d0", "type": "registration-schemas"}}, "provider": {"links": {"related": {"href": "https://api.osf.io/v2/providers/registrations/osf/?format=json", "meta": {}}}}}, "links": {"html": "https://osf.io/cf639/", "self": "https://api.osf.io/v2/registrations/cf639/"}}, {"id": "n4e9z", "type": "registrations", "attributes": {"title": "Mapping population mental health concerns related to COVID-19 and the consequences of physical distancing: a Google trends analysis", "description": "The 2020 Coronavirus pandemic is a major international public health challenge.  Governments have taken public health protection measures to reduce the spread of the virus through non-pharamlogocial measures. The impact of the pandemic and the public health response on individual and population mental health is unknown.   Methods: We used Google Trends data (1 Jan 2020 - 1 Apr 2020) to investigate the impact of the pandemic and government measures to curb it on people\u2019s concerns, as indexed by changes in search frequency for topics indicating mental distress, social and economic stressors and mental health treatment-seeking.", "category": "data", "custom_citation": "", "date_created": "2020-04-16T12:41:33.530399", "date_modified": "2020-04-18T05:01:56.081328", "registration": true, "preprint": false, "fork": false, "collection": false, "tags": [], "access_requests_enabled": false, "node_license": {"copyright_holders": [], "year": null}, "analytics_key": "df771886f89bc091b1db726f880cfb5b9bdd1dc4e12e0d17a6420dc62c481561aa7f58d01845927be23d8dfc60f350766b69333d69d44f3998c6e819d4fd69647008e4509c4e9ecc1e878afec399582e70912f126585ea6c5f0c84ccb4e246c54c8ee113892c51ed2b4a436f84e59a7d6002fa93404185946744b79c59295fbfe3f35831103584f71c91e2552e77985b", "current_user_can_comment": false, "current_user_permissions": ["read"], "current_user_is_contributor": false, "current_user_is_contributor_or_group_member": false, "wiki_enabled": true, "public": true, "article_doi": null, "pending_embargo_approval": false, "pending_embargo_termination_approval": false, "embargoed": false, "pending_registration_approval": false, "archiving": false, "pending_withdrawal": true, "withdrawn": false, "date_registered": "2020-04-16T12:41:33.509318", "date_withdrawn": null, "embargo_end_date": null, "withdrawal_justification": "not enough data associated with the registration - need to resubmit", "registration_supplement": "Open-Ended Registration", "registered_meta": {"summary": {"extra": [], "value": "Data associated with publication"}, "uploader": {"extra": [{"data": {"name": "coviddata2020mainFINAL.xls"}, "nodeId": "pxgte", "sha256": "f50cb7e3ee3d18a0e06924d3bc1b82a586e84d351ec06c1e4b01017a867ad4d3", "viewUrl": "/project/pxgte/files/osfstorage/5e98504ff13535051dd5564d", "selectedFileName": "coviddata2020mainFINAL.xls"}], "value": ""}}, "registration_responses": {"summary": "Data associated with publication", "uploader": [{"file_id": "5e98504ff13535051dd5564d", "file_name": "coviddata2020mainFINAL.xls", "file_urls": {"html": "https://osf.io/pxgte/files/osfstorage/5e98504ff13535051dd5564d", "download": "https://osf.io/download/5e98504ff13535051dd5564d/"}, "file_hashes": {"sha256": "f50cb7e3ee3d18a0e06924d3bc1b82a586e84d351ec06c1e4b01017a867ad4d3"}}]}, "subjects": [[{"id": "584240da54be81056cecaaaa", "text": "Medicine and Health Sciences"}]]}, "relationships": {"license": {"links": {"related": {"href": "https://api.osf.io/v2/licenses/563c1cf88c5e4a3877f9e96c/?format=json", "meta": {}}}, "data": {"id": "563c1cf88c5e4a3877f9e96c", "type": "licenses"}}, "children": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n4e9z/children/?format=json", "meta": {}}}}, "comments": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n4e9z/comments/?format=json&filter%5Btarget%5D=n4e9z", "meta": {}}}}, "contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n4e9z/contributors/?format=json", "meta": {}}}}, "bibliographic_contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n4e9z/bibliographic_contributors/?format=json", "meta": {}}}}, "implicit_contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n4e9z/implicit_contributors/?format=json", "meta": {}}}}, "files": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n4e9z/files/?format=json", "meta": {}}}}, "wikis": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n4e9z/wikis/?format=json", "meta": {}}}}, "forks": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n4e9z/forks/?format=json", "meta": {}}}}, "node_links": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n4e9z/node_links/?format=json", "meta": {}}}}, "linked_by_nodes": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n4e9z/linked_by_nodes/?format=json", "meta": {}}}}, "linked_by_registrations": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n4e9z/linked_by_registrations/?format=json", "meta": {}}}}, "identifiers": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n4e9z/identifiers/?format=json", "meta": {}}}}, "affiliated_institutions": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n4e9z/institutions/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/n4e9z/relationships/institutions/?format=json", "meta": {}}}}, "region": {"links": {"related": {"href": "https://api.osf.io/v2/regions/de-1/?format=json", "meta": {}}}, "data": {"id": "de-1", "type": "regions"}}, "root": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n4e9z/?format=json", "meta": {}}}, "data": {"id": "n4e9z", "type": "registrations"}}, "logs": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n4e9z/logs/?format=json", "meta": {}}}}, "linked_nodes": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n4e9z/linked_nodes/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/n4e9z/relationships/linked_nodes/?format=json", "meta": {}}}}, "linked_registrations": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n4e9z/linked_registrations/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/n4e9z/relationships/linked_registrations/?format=json", "meta": {}}}}, "view_only_links": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n4e9z/view_only_links/?format=json", "meta": {}}}}, "citation": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/n4e9z/citation/?format=json", "meta": {}}}, "data": {"id": "n4e9z", "type": "registrations"}}, "registered_by": {"links": {"related": {"href": "https://api.osf.io/v2/users/5u8bm/?format=json", "meta": {}}}, "data": {"id": "5u8bm", "type": "users"}}, "registered_from": {"links": {"related": {"href": "https://api.osf.io/v2/nodes/pxgte/?format=json", "meta": {}}}, "data": {"id": "pxgte", "type": "nodes"}}, "registration_schema": {"links": {"related": {"href": "https://api.osf.io/v2/schemas/registrations/5df83f7dd28338001ac0ab0d/?format=json", "meta": {}}}, "data": {"id": "5df83f7dd28338001ac0ab0d", "type": "registration-schemas"}}, "provider": {"links": {"related": {"href": "https://api.osf.io/v2/providers/registrations/osf/?format=json", "meta": {}}}}}, "links": {"html": "https://osf.io/n4e9z/", "self": "https://api.osf.io/v2/registrations/n4e9z/"}}, {"id": "uf62n", "type": "registrations", "attributes": {"title": "Incidence of melanoma in Canada according to socioeconomic status: a systematic review and meta-analysis.", "description": "", "category": "project", "custom_citation": "", "date_created": "2020-02-17T22:08:19.422044", "date_modified": "2020-04-20T17:19:26.387905", "registration": true, "preprint": false, "fork": false, "collection": false, "tags": [], "access_requests_enabled": false, "node_license": null, "analytics_key": "58b10e8354d284119d4acce3d653b4b16b22159ca97a8debacf05f39887cf1755209219a541c2d70574dfa71d6a352f6f1d6d4447e2a50a972ba0070a7dffa3d0eeae1b61b4e019bd44683d603b441a58d4155a844ede8b31f1db6dad1587b2871f61b8296ab3fb5baab7958cf5115608057df12e8ffa369f508d941e58f3705a2af65838c471ed3931d977dad38027b", "current_user_can_comment": false, "current_user_permissions": ["read"], "current_user_is_contributor": false, "current_user_is_contributor_or_group_member": false, "wiki_enabled": true, "public": true, "article_doi": null, "pending_embargo_approval": false, "pending_embargo_termination_approval": false, "embargoed": false, "pending_registration_approval": false, "archiving": false, "pending_withdrawal": false, "withdrawn": false, "date_registered": "2020-02-17T22:08:19.384249", "date_withdrawn": null, "embargo_end_date": null, "withdrawal_justification": null, "registration_supplement": "Open-Ended Registration", "registered_meta": {"summary": {"extra": [], "value": "1. * Review title.\nIncidence of Melanoma According to Socioeconomic Status in Canada: A Systematic Review and Meta-Analysis\n\n2. * Anticipated or actual start date.\nGive the date when the systematic review commenced, or is expected to commence.\n01/02/2020\n\n3. * Anticipated completion date.\nGive the date by which the review is expected to be completed.\n01/05/2020\n\n4. * Stage of review at time of this submission.\nData extraction has not started.\n\n5. * Named contact.\nThe named contact acts as the guarantor for the accuracy of the information presented in the register record.\nAdrian Bailey\nEmail salutation (e.g. \"Dr Smith\" or \"Joanne\") for correspondence:\nMr. Bailey\n\n6. * Named contact email.\nGive the electronic mail address of the named contact.\nabail082@uottawa.ca\n\n8. Named contact phone number.\nGive the telephone number for the named contact, including international dialling code.\n6138585029\n\n9. * Organisational affiliation of the review.\nUniversity of Ottawa\n\n10. * Funding sources/sponsors.\nGive details of the individuals, organizations, groups or other legal entities who take responsibility for initiating, managing, sponsoring and/or financing the review. Include any unique identification numbers assigned to the review by the individuals or bodies listed.\nNone\n\n11. * Conflicts of interest.\nList any conditions that could lead to actual or perceived undue influence on judgements concerning the main topic investigated in the review.\nNone.\n\n15. * Review question.\nState the question(s) to be addressed by the review, clearly and precisely. Review questions may be specific or broad. It may be appropriate to break very broad questions down into a series of related more specific questions. Questions may be framed or refined using PI(E)COS where relevant.\nP: Populations inside of Canada\nI: Low Socioeconomic Status\nC: High Socioeconomic Status\nO: Incidence of Melanoma\n\n16. * Searches.\nState the sources that will be searched. Give the search dates, and any restrictions (e.g. language or publication period). Do NOT enter the full search strategy (it may be provided as a link or attachment.)\nPubMed and Scopus were searched on February 10th, 2020. The search combined the following key words; socioeconomic, status, and melanoma. Included articles had to be available in English and between the years of 1950-2020.\n\n17. * Condition or domain being studied.\nGive a short description of the disease, condition or healthcare domain being studied. This could include health and wellbeing outcomes.\n\nMelanoma is one of the leading cancers in average years of life lost per death from disease. The worldwide incidence of melanoma has risen rapidly over the course of the last 50 years and is expected to continue rising. In Canada specifically, 72, 565 patients were given primary melanoma (CMM) diagnoses with a steady increase in CMM incidence and mortality rates from 1992-2010. Given the expected rising incidence of melanoma and associated morbidity, a better understanding of the epidemiology and risk factors of melanoma in Canada is required.\n\nThere is increasing evidence supporting a significant association of SES with melanoma incidence and outcomes. For patients from higher SES backgrounds, there appears to be higher melanoma incidence, especially among the highly educated while lower SES populations were more likely to present with later-stage disease at time of diagnosis and greater mortality.\n\nHowever, the majority of these studies were conducted in countries without universal health care, thus limiting the generalizability of these findings in Canada, a country with a universal healthcare system. Although several Canadian studies have supported these findings, it is unclear the effect of socioeconomic status (SES) on melanoma incidence and outcomes.\n\n18. * Participants/population.\nGive summary criteria for the participants or populations being studied by the review. The preferred format includes details of both inclusion and exclusion criteria.\n\nInclusion criteria:\n-Canadian patients of all ages, ethnicities, and socioeconomic status.\n\nExclusion criteria:\n-Patients outside of Canada.\n\n19. * Intervention(s), exposure(s).\nGive full and clear descriptions or definitions of the nature of the interventions or the exposures to be reviewed.\n\nThe \"intervention\" is low socioeconomic status, determined in any manner. Essentially, this review aims to assess the difference in incidence of melanoma between high and low socioeconomic status.\n\n20. * Comparator(s)/control.\nWhere relevant, give details of the alternatives against which the main subject/topic of the review will be compared (e.g. another intervention or a non-exposed control group). The preferred format includes details of both inclusion and exclusion criteria.\nPatients/populations in Canada of high socioeconomic status, determined in any manner.\n\n21. * Types of study to be included.\nGive details of the types of study (study designs) eligible for inclusion in the review. If there are no restrictions on the types of study design eligible for inclusion, or certain study types are excluded, this should be stated. The preferred format includes details of both inclusion and exclusion criteria.\n\nInclusion criteria:\n-Papers published before January 1st, 2020 in peer-reviewed journals.\n-Articles available in English language only.\n-Papers will include RCTs, quasi-experimental studies, cohort studies, case control studies, case studies, cross sectional studies, longitudinal studies, systematic reviews, quantitative, qualitative and mixed methods studies.\n\nExclusion criteria:\n-Editorials, commentaries, discussion or reviews, position papers.\n\n22. * Main outcome(s).\nGive the pre-specified main (most important) outcomes of the review, including details of how the outcome is defined and measured and when these measurement are made, if these are part of the review inclusion criteria.\n\n-Incidence of Melanoma\n-Incidence of Advanced Melanoma\n-Survival\n\n* Measures of effect\nPlease specify the effect measure(s) for you main outcome(s) e.g. relative risks, odds ratios, risk difference, and/or 'number needed to treat.\n\nThe generic inverse variance method will be used to estimate odd's ratio and rate ratio for included studies.\n\n23. * Additional outcome(s).\nList the pre-specified additional outcomes of the review, with a similar level of detail to that required for main outcomes. Where there are no additional outcomes please state \u2018None\u2019 or \u2018Not applicable\u2019 as appropriate to the review\nNone.\n\n* Measures of effect\nPlease specify the effect measure(s) for you additional outcome(s) e.g. relative risks, odds ratios, risk difference, and/or 'number needed to treat.\n\nNot applicable\n\n24. * Data extraction (selection and coding).\nDescribe how studies will be selected for inclusion. State what data will be extracted or obtained. State how this will be done and recorded.\n\nStudy selection:\n\u2022 Two independent, blinded reviewers will apply the inclusion and exclusion criteria to select studies for inclusion into the systematic review. Discrepancies will be resolved by a third reviewer, the supervisor of the study.\n\u2022 Excel software will be used to record decisions.\n\nData extraction:\n\u2022 Information about and not limited to study design and methodology, participant demographics will be recorded. Study authors will not be contacted for additional information.\n\u2022 Two independent, blinded reviewers will extract data from select studies. Less than 5% error between reviewers will be acceptable in cases where estimation is required (i.e., using ImageJ software to estimate values from Figures when the data is not reported in text or supplemental materials). Discrepancies will be resolved by a third reviewer, the supervisor of the study.\n\u2022 Excel software will be used to record data.\n\n25. * Risk of bias (quality) assessment.\nDescribe the method of assessing risk of bias or quality assessment. State which characteristics of the studies will be assessed and any formal risk of bias tools that will be used.\n\n\u2022 The Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies AND the Quality Assessment of Case-Control Studies will be used to assess the quality of included studies. Both these tools are from the National Heart, Lung, and Blood institute (https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools).\n\u2022 Two independent, blinded reviewers will use these tools to assess the risk of bias and quality of studies. Discrepancies will be resolved by a third reviewer, the supervisor of the study.\n\u2022 Assessment will be done at the study level.\n\n26. * Strategy for data synthesis.\nProvide details of the planned synthesis including a rationale for the methods selected. This must not be generic text but should be specific to your review and describe how the proposed analysis will be applied to your data.\n\n\u2022 Data will only be synthesized if there are more than two studies that report on the same outcome.\n\u2022 Outcomes will be analysed and plotted separately. Odd's Ratio and Rate Ratio will be plotted separately. Relative risk will be used to estimate a study's Odd's ratio when necessary. Studies using adjusted models (i.e. adjusting for confounders) will be plotted separately to assess for any change in study conclusions due to this adjustment. In addition, Odd's Ratios and Rate Ratios of advanced/invasive melanoma will be plotted separately from all stage melanoma data.\n\u2022 The generic inverse variance in a random-effects meta-analysis for quantitative data will be used to pool data for studies reporting Odd's ratio and Rate Ratio.\n\n27. * Analysis of subgroups or subsets.\nState any planned investigation of \u2018subgroups\u2019. Be clear and specific about which type of study or participant will be included in each group or covariate investigated. State the planned analytic approach.\nNo subgroup analysis is planned.\n\n28. Language.\nSelect each language individually to add it to the list below, use the bin icon  to remove any added in error.\nEnglish\n\n29. * Country.\nSelect the country in which the review is being carried out from the drop down list. For multi-national collaborations select all the countries involved.\nCanada\n\n30. Dissemination plans.\nGive brief details of plans for communicating essential messages from the review to the appropriate audiences.\nPublication to peer-reviewed journal indexed in PubMed.\nDo you intend to publish the review on completion?\nYes\n\n31. Keywords.\nGive words or phrases that best describe the review. Separate keywords with a semicolon or new line. Keywords will help users find the review in the Register (the words do not appear in the public record but are included in searches). Be as specific and precise as possible. Avoid acronyms and abbreviations unless these are in wide use.\n\nMelanoma; socioeconomic; status; Canada; advanced; all stage; incidence\n\n32. * Current review status.\nReview status should be updated when the review is completed and when it is published. For new registrations the review must be Ongoing.\n\nOngoing\n\n\n\n\n\n"}, "uploader": {"extra": [], "value": ""}}, "registration_responses": {"summary": "1. * Review title.\nIncidence of Melanoma According to Socioeconomic Status in Canada: A Systematic Review and Meta-Analysis\n\n2. * Anticipated or actual start date.\nGive the date when the systematic review commenced, or is expected to commence.\n01/02/2020\n\n3. * Anticipated completion date.\nGive the date by which the review is expected to be completed.\n01/05/2020\n\n4. * Stage of review at time of this submission.\nData extraction has not started.\n\n5. * Named contact.\nThe named contact acts as the guarantor for the accuracy of the information presented in the register record.\nAdrian Bailey\nEmail salutation (e.g. \"Dr Smith\" or \"Joanne\") for correspondence:\nMr. Bailey\n\n6. * Named contact email.\nGive the electronic mail address of the named contact.\nabail082@uottawa.ca\n\n8. Named contact phone number.\nGive the telephone number for the named contact, including international dialling code.\n6138585029\n\n9. * Organisational affiliation of the review.\nUniversity of Ottawa\n\n10. * Funding sources/sponsors.\nGive details of the individuals, organizations, groups or other legal entities who take responsibility for initiating, managing, sponsoring and/or financing the review. Include any unique identification numbers assigned to the review by the individuals or bodies listed.\nNone\n\n11. * Conflicts of interest.\nList any conditions that could lead to actual or perceived undue influence on judgements concerning the main topic investigated in the review.\nNone.\n\n15. * Review question.\nState the question(s) to be addressed by the review, clearly and precisely. Review questions may be specific or broad. It may be appropriate to break very broad questions down into a series of related more specific questions. Questions may be framed or refined using PI(E)COS where relevant.\nP: Populations inside of Canada\nI: Low Socioeconomic Status\nC: High Socioeconomic Status\nO: Incidence of Melanoma\n\n16. * Searches.\nState the sources that will be searched. Give the search dates, and any restrictions (e.g. language or publication period). Do NOT enter the full search strategy (it may be provided as a link or attachment.)\nPubMed and Scopus were searched on February 10th, 2020. The search combined the following key words; socioeconomic, status, and melanoma. Included articles had to be available in English and between the years of 1950-2020.\n\n17. * Condition or domain being studied.\nGive a short description of the disease, condition or healthcare domain being studied. This could include health and wellbeing outcomes.\n\nMelanoma is one of the leading cancers in average years of life lost per death from disease. The worldwide incidence of melanoma has risen rapidly over the course of the last 50 years and is expected to continue rising. In Canada specifically, 72, 565 patients were given primary melanoma (CMM) diagnoses with a steady increase in CMM incidence and mortality rates from 1992-2010. Given the expected rising incidence of melanoma and associated morbidity, a better understanding of the epidemiology and risk factors of melanoma in Canada is required.\n\nThere is increasing evidence supporting a significant association of SES with melanoma incidence and outcomes. For patients from higher SES backgrounds, there appears to be higher melanoma incidence, especially among the highly educated while lower SES populations were more likely to present with later-stage disease at time of diagnosis and greater mortality.\n\nHowever, the majority of these studies were conducted in countries without universal health care, thus limiting the generalizability of these findings in Canada, a country with a universal healthcare system. Although several Canadian studies have supported these findings, it is unclear the effect of socioeconomic status (SES) on melanoma incidence and outcomes.\n\n18. * Participants/population.\nGive summary criteria for the participants or populations being studied by the review. The preferred format includes details of both inclusion and exclusion criteria.\n\nInclusion criteria:\n-Canadian patients of all ages, ethnicities, and socioeconomic status.\n\nExclusion criteria:\n-Patients outside of Canada.\n\n19. * Intervention(s), exposure(s).\nGive full and clear descriptions or definitions of the nature of the interventions or the exposures to be reviewed.\n\nThe \"intervention\" is low socioeconomic status, determined in any manner. Essentially, this review aims to assess the difference in incidence of melanoma between high and low socioeconomic status.\n\n20. * Comparator(s)/control.\nWhere relevant, give details of the alternatives against which the main subject/topic of the review will be compared (e.g. another intervention or a non-exposed control group). The preferred format includes details of both inclusion and exclusion criteria.\nPatients/populations in Canada of high socioeconomic status, determined in any manner.\n\n21. * Types of study to be included.\nGive details of the types of study (study designs) eligible for inclusion in the review. If there are no restrictions on the types of study design eligible for inclusion, or certain study types are excluded, this should be stated. The preferred format includes details of both inclusion and exclusion criteria.\n\nInclusion criteria:\n-Papers published before January 1st, 2020 in peer-reviewed journals.\n-Articles available in English language only.\n-Papers will include RCTs, quasi-experimental studies, cohort studies, case control studies, case studies, cross sectional studies, longitudinal studies, systematic reviews, quantitative, qualitative and mixed methods studies.\n\nExclusion criteria:\n-Editorials, commentaries, discussion or reviews, position papers.\n\n22. * Main outcome(s).\nGive the pre-specified main (most important) outcomes of the review, including details of how the outcome is defined and measured and when these measurement are made, if these are part of the review inclusion criteria.\n\n-Incidence of Melanoma\n-Incidence of Advanced Melanoma\n-Survival\n\n* Measures of effect\nPlease specify the effect measure(s) for you main outcome(s) e.g. relative risks, odds ratios, risk difference, and/or 'number needed to treat.\n\nThe generic inverse variance method will be used to estimate odd's ratio and rate ratio for included studies.\n\n23. * Additional outcome(s).\nList the pre-specified additional outcomes of the review, with a similar level of detail to that required for main outcomes. Where there are no additional outcomes please state \u2018None\u2019 or \u2018Not applicable\u2019 as appropriate to the review\nNone.\n\n* Measures of effect\nPlease specify the effect measure(s) for you additional outcome(s) e.g. relative risks, odds ratios, risk difference, and/or 'number needed to treat.\n\nNot applicable\n\n24. * Data extraction (selection and coding).\nDescribe how studies will be selected for inclusion. State what data will be extracted or obtained. State how this will be done and recorded.\n\nStudy selection:\n\u2022 Two independent, blinded reviewers will apply the inclusion and exclusion criteria to select studies for inclusion into the systematic review. Discrepancies will be resolved by a third reviewer, the supervisor of the study.\n\u2022 Excel software will be used to record decisions.\n\nData extraction:\n\u2022 Information about and not limited to study design and methodology, participant demographics will be recorded. Study authors will not be contacted for additional information.\n\u2022 Two independent, blinded reviewers will extract data from select studies. Less than 5% error between reviewers will be acceptable in cases where estimation is required (i.e., using ImageJ software to estimate values from Figures when the data is not reported in text or supplemental materials). Discrepancies will be resolved by a third reviewer, the supervisor of the study.\n\u2022 Excel software will be used to record data.\n\n25. * Risk of bias (quality) assessment.\nDescribe the method of assessing risk of bias or quality assessment. State which characteristics of the studies will be assessed and any formal risk of bias tools that will be used.\n\n\u2022 The Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies AND the Quality Assessment of Case-Control Studies will be used to assess the quality of included studies. Both these tools are from the National Heart, Lung, and Blood institute (https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools).\n\u2022 Two independent, blinded reviewers will use these tools to assess the risk of bias and quality of studies. Discrepancies will be resolved by a third reviewer, the supervisor of the study.\n\u2022 Assessment will be done at the study level.\n\n26. * Strategy for data synthesis.\nProvide details of the planned synthesis including a rationale for the methods selected. This must not be generic text but should be specific to your review and describe how the proposed analysis will be applied to your data.\n\n\u2022 Data will only be synthesized if there are more than two studies that report on the same outcome.\n\u2022 Outcomes will be analysed and plotted separately. Odd's Ratio and Rate Ratio will be plotted separately. Relative risk will be used to estimate a study's Odd's ratio when necessary. Studies using adjusted models (i.e. adjusting for confounders) will be plotted separately to assess for any change in study conclusions due to this adjustment. In addition, Odd's Ratios and Rate Ratios of advanced/invasive melanoma will be plotted separately from all stage melanoma data.\n\u2022 The generic inverse variance in a random-effects meta-analysis for quantitative data will be used to pool data for studies reporting Odd's ratio and Rate Ratio.\n\n27. * Analysis of subgroups or subsets.\nState any planned investigation of \u2018subgroups\u2019. Be clear and specific about which type of study or participant will be included in each group or covariate investigated. State the planned analytic approach.\nNo subgroup analysis is planned.\n\n28. Language.\nSelect each language individually to add it to the list below, use the bin icon  to remove any added in error.\nEnglish\n\n29. * Country.\nSelect the country in which the review is being carried out from the drop down list. For multi-national collaborations select all the countries involved.\nCanada\n\n30. Dissemination plans.\nGive brief details of plans for communicating essential messages from the review to the appropriate audiences.\nPublication to peer-reviewed journal indexed in PubMed.\nDo you intend to publish the review on completion?\nYes\n\n31. Keywords.\nGive words or phrases that best describe the review. Separate keywords with a semicolon or new line. Keywords will help users find the review in the Register (the words do not appear in the public record but are included in searches). Be as specific and precise as possible. Avoid acronyms and abbreviations unless these are in wide use.\n\nMelanoma; socioeconomic; status; Canada; advanced; all stage; incidence\n\n32. * Current review status.\nReview status should be updated when the review is completed and when it is published. For new registrations the review must be Ongoing.\n\nOngoing\n\n\n\n\n\n", "uploader": []}, "subjects": []}, "relationships": {"children": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/uf62n/children/?format=json", "meta": {}}}}, "comments": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/uf62n/comments/?format=json&filter%5Btarget%5D=uf62n", "meta": {}}}}, "contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/uf62n/contributors/?format=json", "meta": {}}}}, "bibliographic_contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/uf62n/bibliographic_contributors/?format=json", "meta": {}}}}, "implicit_contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/uf62n/implicit_contributors/?format=json", "meta": {}}}}, "files": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/uf62n/files/?format=json", "meta": {}}}}, "wikis": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/uf62n/wikis/?format=json", "meta": {}}}}, "forks": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/uf62n/forks/?format=json", "meta": {}}}}, "node_links": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/uf62n/node_links/?format=json", "meta": {}}}}, "linked_by_nodes": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/uf62n/linked_by_nodes/?format=json", "meta": {}}}}, "linked_by_registrations": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/uf62n/linked_by_registrations/?format=json", "meta": {}}}}, "identifiers": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/uf62n/identifiers/?format=json", "meta": {}}}}, "affiliated_institutions": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/uf62n/institutions/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/uf62n/relationships/institutions/?format=json", "meta": {}}}}, "region": {"links": {"related": {"href": "https://api.osf.io/v2/regions/us/?format=json", "meta": {}}}, "data": {"id": "us", "type": "regions"}}, "root": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/uf62n/?format=json", "meta": {}}}, "data": {"id": "uf62n", "type": "registrations"}}, "logs": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/uf62n/logs/?format=json", "meta": {}}}}, "linked_nodes": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/uf62n/linked_nodes/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/uf62n/relationships/linked_nodes/?format=json", "meta": {}}}}, "linked_registrations": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/uf62n/linked_registrations/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/uf62n/relationships/linked_registrations/?format=json", "meta": {}}}}, "view_only_links": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/uf62n/view_only_links/?format=json", "meta": {}}}}, "citation": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/uf62n/citation/?format=json", "meta": {}}}, "data": {"id": "uf62n", "type": "registrations"}}, "registered_by": {"links": {"related": {"href": "https://api.osf.io/v2/users/rm6y9/?format=json", "meta": {}}}, "data": {"id": "rm6y9", "type": "users"}}, "registered_from": {"links": {"related": {"href": "https://api.osf.io/v2/nodes/s9xf6/?format=json", "meta": {}}}, "data": {"id": "s9xf6", "type": "nodes"}}, "registration_schema": {"links": {"related": {"href": "https://api.osf.io/v2/schemas/registrations/5df83f7dd28338001ac0ab0d/?format=json", "meta": {}}}, "data": {"id": "5df83f7dd28338001ac0ab0d", "type": "registration-schemas"}}, "provider": {"links": {"related": {"href": "https://api.osf.io/v2/providers/registrations/osf/?format=json", "meta": {}}}}}, "links": {"html": "https://osf.io/uf62n/", "self": "https://api.osf.io/v2/registrations/uf62n/"}}, {"id": "e2fv3", "type": "registrations", "attributes": {"title": "The effectiveness of microneedling compared to placebo in the treatement of melasma: A systematic review and meta-analysis.", "description": "1. * Review title.\n\nThe effectiveness of microneedling compared to placebo in the treatement of melasma: A systematic review and meta-analysis.\n\n2. * Anticipated or actual start date.\nGive the date when the systematic review commenced, or is expected to commence.\n28/02/2020\n\n3. * Anticipated completion date.\nGive the date by which the review is expected to be completed.\n20/04/2020\n\n4. * Stage of review at time of this submission.\nReview stage\tStarted\tCompleted\nPreliminary searches\t\t\nPiloting of the study selection process\t\t\nFormal screening of search results against eligibility criteria\t\t\nData extraction\t\t\nRisk of bias (quality) assessment\t\t\nData analysis\t\t\nProvide any other relevant information about the stage of the review here (e.g. Funded proposal, protocol not yet finalised).\n\n5. * Named contact.\nThe named contact acts as the guarantor for the accuracy of the information presented in the register record.\nAdrian Bailey\nEmail salutation (e.g. \"Dr Smith\" or \"Joanne\") for correspondence:\nMr Bailey\n\n6. * Named contact email.\nGive the electronic mail address of the named contact.\nabail082@uottawa.ca\n\n7. Named contact address\nPLEASE NOTE this information will be published in the PROSPERO record so please do not enter private information\nGive the full postal address for the named contact.\n4512 Appleton Side Road\n\n8. Named contact phone number.\nGive the telephone number for the named contact, including international dialling code.\n6138585029\n\n9. * Organisational affiliation of the review.\nFull title of the organisational affiliations for this review and website address if available. This field may be completed as 'None' if the review is not affiliated to any organisation.\nUniversity of Ottawa\n\n10. * Review team members and their organisational affiliations.\nGive the personal details and the organisational affiliations of each member of the review team. Affiliation refers to groups or organisations to which review team members belong. NOTE: email and country are now mandatory fields for each person.\n\nAdrian Bailey - University of Ottawa\n\nHeidi Li - University of Ottawa\n\n11. * Funding sources/sponsors.\nGive details of the individuals, organizations, groups or other legal entities who take responsibility for initiating, managing, sponsoring and/or financing the review. Include any unique identification numbers assigned to the review by the individuals or bodies listed.\nNone\n\n12. * Conflicts of interest.\nList any conditions that could lead to actual or perceived undue influence on judgements concerning the main topic investigated in the review.\nNone\n\n13. Collaborators.\nGive the name and affiliation of any individuals or organisations who are working on the review but who are not listed as review team members. NOTE: email and country are now mandatory fields for each person.\nNone\n\n14. * Review question.\nState the question(s) to be addressed by the review, clearly and precisely. Review questions may be specific or broad. It may be appropriate to break very broad questions down into a series of related more specific questions. Questions may be framed or refined using PI(E)COS where relevant.\nP = adult patients (&gt;18 years old) with melasma\nI = microneedling\nC = control intervention (topical treatments, oral tranexamic acid, placebo)\nO = Melasma Area and Severity Index or modified Melasma Area and Severity Index\nS = Randomized controlled trial, Prospective studies\n\n15. * Searches.\nState the sources that will be searched. Give the search dates, and any restrictions (e.g. language or publication period). Do NOT enter the full search strategy (it may be provided as a link or attachment.)\nA systematic search without date restrictions was conducted in MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials on March 4th, 2020, using a search strategy developed in conjunction with a librarian specializing in systematic review searches. The search strategy was consistent across all databases.\n\n16. * Condition or domain being studied.\nGive a short description of the disease, condition or healthcare domain being studied. This could include health and wellbeing outcomes.\nMelasma is an acquired, symmetrical disorder of hypermelanosis that affects the sun-exposed areas of the skin. To-date, there does not exist a satisfactory treatment for melasma. A variety of topical and systemic treatments have been attempted, including laser therapy, oral and topical tranexamic acid, and combination therapies. In particular, many studies have explored the use of microneedling in melasma and have shown promising results. However, to-date, the literature lacks a systematic review and meta-analysis on the effectiveness of microneedling in the treatment of melasma.\n\n17. * Participants/population.\nGive summary criteria for the participants or populations being studied by the review. The preferred format includes details of both inclusion and exclusion criteria.\nAdult patients with melasma (&gt;18 years old). Pediatric patients are excluded.\n\n18. * Intervention(s), exposure(s).\nGive full and clear descriptions or definitions of the nature of the interventions or the exposures to be reviewed.\nMicroneedling, either alone or in combination with another therapy. Ex. Platelet rich plasma, tranexamic acid (oral and topical), vitamin C, depigmentation serum.\n\n19. * Comparator(s)/control.\nWhere relevant, give details of the alternatives against which the main subject/topic of the review will be compared (e.g. another intervention or a non-exposed control group). The preferred format includes details of both inclusion and exclusion criteria.\nAny control. Ex. Placebo, microinjections.\n\n20. * Types of study to be included.\nGive details of the types of study (study designs) eligible for inclusion in the review. If there are no restrictions on the types of study design eligible for inclusion, or certain study types are excluded, this should be stated. The preferred format includes details of both inclusion and exclusion criteria.\nAll English-language full-text articles that report on microneedling or microneedling combined with another intervention, such as tranexamic acid, lasers, and platelet plasma, for the treatment of melasma are included. Eligible study designs include prospective cohort, randomized controlled trials (RCT), and quasi-randomized clinical trials. Included studies are required to be comparative, either through split-faced design or experimental and control group design.\n\nStudies that used microinjections or radiofrequency microneedling are excluded. Studies using baseline as a comparison are excluded along with retrospective cohort, case-reports, case series, reviews, and grey literature.\n\n21. * Main outcome(s).\nGive the pre-specified main (most important) outcomes of the review, including details of how the outcome is defined and measured and when these measurement are made, if these are part of the review inclusion criteria.\nOutcome = Melasma Area and Severity Index.\n\nAll variations of the MASI score (MASI and modified MASI) are accepted and will be directly compared.\n175 words remaining\n* Measures of effect\nPlease specify the effect measure(s) for you main outcome(s) e.g. relative risks, odds ratios, risk difference, and/or 'number needed to treat.\n\nMean difference between Melasma Area and Severity Index (MASI) scores at baseline and endpoint for both the intervention and control groups.\n\n22. * Additional outcome(s).\nList the pre-specified additional outcomes of the review, with a similar level of detail to that required for main outcomes. Where there are no additional outcomes please state \u2018None\u2019 or \u2018Not applicable\u2019 as appropriate to the review\nN/A\n\n* Measures of effect\nPlease specify the effect measure(s) for you additional outcome(s) e.g. relative risks, odds ratios, risk difference, and/or 'number needed to treat.\nN/A\n\n23. * Data extraction (selection and coding).\nDescribe how studies will be selected for inclusion. State what data will be extracted or obtained. State how this will be done and recorded.\nIn order to be included in the meta-analysis, studies have to provide the difference between Melasma Area and Severity Index (MASI) scores at baseline and endpoint for both the intervention and control groups or provide sufficient data for these values to be calculated. All variations of the MASI score (MASI and modified MASI) are accepted and directly compared. Studies using baseline as a comparison are excluded.\n\nIn the next step, the characteristics and results of the studies will be extracted. This will include demographic data of each of the studies (authors, country of origin, date of publication) and details of the study\u2019s design (age range, number, and sex of participants, interventions in the control group and experimental arm). The difference in MASI scores (mean and standard deviation) of the intervention and control groups between baseline and endpoint for each of the studies will be extracted or calculated. If necessary, ImageJ will be used to estimate values from figures, and corresponding authors will be contacted for missing data. Data will be stored and compared using Excel Software in duplicates.\n\n24. * Risk of bias (quality) assessment.\nDescribe the method of assessing risk of bias or quality assessment. State which characteristics of the studies will be assessed and any formal risk of bias tools that will be used.\nThe Cochrane risk of bias tool 2 (reference) will be used to assess the quality of the included studies. Studies of any risk of bias will be included in the meta-analysis, but separate analysis will be conducted with these studies excluded.\n\n25. * Strategy for data synthesis.\nProvide details of the planned synthesis including a rationale for the methods selected. This must not be generic text but should be specific to your review and describe how the proposed analysis will be applied to your data.\nReview Manager Software (version 5.3) will be used. The DerSimonian-Laird random-effects model for the meta-analysis of continuous data will be applied. Results will be displayed as the mean difference between baseline and endpoint MASI scores for both the intervention and control groups, with 95% Confidence Intervals (CI). In the pooled analysis, studies using systemic therapy, such as oral tranexamic acid, will be separated from studies using topical therapies, such as topical tranexamic acid. I\u00b2 statistic will be used to asses heterogeneity across studies. Funnel plots will be used to assess for publication bias. The Bonferroni correction will be applied to account for multiple testing in the subgroup analysis, with P &lt; 0.01 being considered significant. P&lt; 0.05 will be considered as significant in all other analyses.\n\n26. * Analysis of subgroups or subsets.\nState any planned investigation of \u2018subgroups\u2019. Be clear and specific about which type of study or participant will be included in each group or covariate investigated. State the planned analytic approach.\nSubgroup analyses will be performed on studies that compare microneedling to placebo and for studies that used microneedling in both the intervention and control groups.\n\n27. * Type and method of review.\nSelect the type of review and the review method from the lists below. Select the health area(s) of interest for your review.\nType of review\n\n28. Language.\nSelect each language individually to add it to the list below, use the bin icon  to remove any added in error.\nEnglish\n\n29. * Country.\nSelect the country in which the review is being carried out from the drop down list. For multi-national collaborations select all the countries involved.\nCanada\n\n30. Other registration details.\nGive the name of any organisation where the systematic review title or protocol is registered (such as with The Campbell Collaboration, or The Joanna Briggs Institute) together with any unique identification number assigned. (N.B. Registration details for Cochrane protocols will be automatically entered). If extracted data will be stored and made available through a repository such as the Systematic Review Data Repository (SRDR), details and a link should be included here. If none, leave blank.\n\nAlso pending registration on PROSPERO on 15th April 2020.\n\n31. Dissemination plans.\nGive brief details of plans for communicating essential messages from the review to the appropriate audiences.\nDo you intend to publish the review on completion?\nYes\n\n\n32. * Current review status.\nReview status should be updated when the review is completed and when it is published. For new registrations the review must be Ongoing.\n\nOngoing", "category": "project", "custom_citation": "", "date_created": "2020-04-16T01:15:42.257010", "date_modified": "2020-04-20T17:09:01.209614", "registration": true, "preprint": false, "fork": false, "collection": false, "tags": ["melasma", "meta-analysis", "microneedling", "systematic review"], "access_requests_enabled": false, "node_license": {"copyright_holders": ["None"], "year": "2020"}, "analytics_key": "82169aebf91ef6260f5567f629f1ccf9dcde1f3e8d073c4107706250b4b008c0910c27d2aa4bbf45f127a8f58f5bd51ce50f597595017402aeb84bd34816ff828403d1fb5c59305fb5fca46a13b5b127ce2d84e5d980aaa683ca4b38c7da57baec7e8bf474252b5dd18a7d4cd8297d0274539f2414cff352f0d6fb35621699836840ecac67b43e73d30d79486b3eb378", "current_user_can_comment": false, "current_user_permissions": ["read"], "current_user_is_contributor": false, "current_user_is_contributor_or_group_member": false, "wiki_enabled": true, "public": true, "article_doi": null, "pending_embargo_approval": false, "pending_embargo_termination_approval": false, "embargoed": false, "pending_registration_approval": false, "archiving": false, "pending_withdrawal": false, "withdrawn": false, "date_registered": "2020-04-16T01:15:42.234230", "date_withdrawn": null, "embargo_end_date": null, "withdrawal_justification": null, "registration_supplement": "Open-Ended Registration", "registered_meta": {"summary": {"extra": [], "value": "Melasma is an acquired, symmetrical disorder of hypermelanosis that affects the sun-exposed areas of the skin. To-date, there does not exist a satisfactory treatment for melasma. A variety of topical and systemic treatments have been attempted, including laser therapy, oral and topical tranexamic acid, and combination therapies. In particular, many studies have explored the use of microneedling in melasma and have shown promising results. However, to-date, the literature lacks a systematic review and meta-analysis on the effectiveness of microneedling in the treatment of melasma."}, "uploader": {"extra": [], "value": ""}}, "registration_responses": {"summary": "Melasma is an acquired, symmetrical disorder of hypermelanosis that affects the sun-exposed areas of the skin. To-date, there does not exist a satisfactory treatment for melasma. A variety of topical and systemic treatments have been attempted, including laser therapy, oral and topical tranexamic acid, and combination therapies. In particular, many studies have explored the use of microneedling in melasma and have shown promising results. However, to-date, the literature lacks a systematic review and meta-analysis on the effectiveness of microneedling in the treatment of melasma."}, "subjects": [[{"id": "584240da54be81056cecaaaa", "text": "Medicine and Health Sciences"}, {"id": "584240d954be81056cecaa5d", "text": "Diseases"}]]}, "relationships": {"license": {"links": {"related": {"href": "https://api.osf.io/v2/licenses/563c1cf88c5e4a3877f9e965/?format=json", "meta": {}}}, "data": {"id": "563c1cf88c5e4a3877f9e965", "type": "licenses"}}, "children": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/e2fv3/children/?format=json", "meta": {}}}}, "comments": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/e2fv3/comments/?format=json&filter%5Btarget%5D=e2fv3", "meta": {}}}}, "contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/e2fv3/contributors/?format=json", "meta": {}}}}, "bibliographic_contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/e2fv3/bibliographic_contributors/?format=json", "meta": {}}}}, "implicit_contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/e2fv3/implicit_contributors/?format=json", "meta": {}}}}, "files": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/e2fv3/files/?format=json", "meta": {}}}}, "wikis": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/e2fv3/wikis/?format=json", "meta": {}}}}, "forks": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/e2fv3/forks/?format=json", "meta": {}}}}, "node_links": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/e2fv3/node_links/?format=json", "meta": {}}}}, "linked_by_nodes": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/e2fv3/linked_by_nodes/?format=json", "meta": {}}}}, "linked_by_registrations": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/e2fv3/linked_by_registrations/?format=json", "meta": {}}}}, "identifiers": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/e2fv3/identifiers/?format=json", "meta": {}}}}, "affiliated_institutions": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/e2fv3/institutions/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/e2fv3/relationships/institutions/?format=json", "meta": {}}}}, "region": {"links": {"related": {"href": "https://api.osf.io/v2/regions/ca-1/?format=json", "meta": {}}}, "data": {"id": "ca-1", "type": "regions"}}, "root": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/e2fv3/?format=json", "meta": {}}}, "data": {"id": "e2fv3", "type": "registrations"}}, "logs": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/e2fv3/logs/?format=json", "meta": {}}}}, "linked_nodes": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/e2fv3/linked_nodes/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/e2fv3/relationships/linked_nodes/?format=json", "meta": {}}}}, "linked_registrations": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/e2fv3/linked_registrations/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/e2fv3/relationships/linked_registrations/?format=json", "meta": {}}}}, "view_only_links": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/e2fv3/view_only_links/?format=json", "meta": {}}}}, "citation": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/e2fv3/citation/?format=json", "meta": {}}}, "data": {"id": "e2fv3", "type": "registrations"}}, "registered_by": {"links": {"related": {"href": "https://api.osf.io/v2/users/rm6y9/?format=json", "meta": {}}}, "data": {"id": "rm6y9", "type": "users"}}, "registered_from": {"links": {"related": {"href": "https://api.osf.io/v2/nodes/28m3h/?format=json", "meta": {}}}, "data": {"id": "28m3h", "type": "nodes"}}, "registration_schema": {"links": {"related": {"href": "https://api.osf.io/v2/schemas/registrations/5df83f7dd28338001ac0ab0d/?format=json", "meta": {}}}, "data": {"id": "5df83f7dd28338001ac0ab0d", "type": "registration-schemas"}}, "provider": {"links": {"related": {"href": "https://api.osf.io/v2/providers/registrations/osf/?format=json", "meta": {}}}}}, "links": {"html": "https://osf.io/e2fv3/", "self": "https://api.osf.io/v2/registrations/e2fv3/"}}, {"id": "dpgs6", "type": "registrations", "attributes": {"title": "The Effects of Child Participation in Dependency Court Proceedings: A Systematic Review", "description": "This systematic review will synthesize academic and gray literature to determine the outcomes associated with child and youth participation in dependency court proceedings, as well as any practices that have been shown to be effective in promoting positive outcomes.", "category": "project", "custom_citation": "", "date_created": "2020-04-20T16:49:36.884948", "date_modified": "2020-04-20T16:36:26.990480", "registration": true, "preprint": false, "fork": false, "collection": false, "tags": [], "access_requests_enabled": false, "node_license": {"copyright_holders": ["None"], "year": "2020"}, "analytics_key": "765fa961e2bac8c6c267199e2850b370e364cbf03dffc78b42bdf57efe29861e67c14b68d03315ad3fd4850b32608033f4e4f1ca943bbf402fe79f30a48b0e19789ce5068c6ada46f8efa4876c464fde8d8c0dae286fa116b102b7082794a8ce65f630ed24f1d38671bc08d30d38fcd5912d20e859fe7b15cb89cdec1bd4d91dc5909a30ab8076ace74eac68cf67f03a", "current_user_can_comment": false, "current_user_permissions": ["read"], "current_user_is_contributor": false, "current_user_is_contributor_or_group_member": false, "wiki_enabled": true, "public": true, "article_doi": null, "pending_embargo_approval": false, "pending_embargo_termination_approval": false, "embargoed": false, "pending_registration_approval": false, "archiving": false, "pending_withdrawal": false, "withdrawn": false, "date_registered": "2020-04-20T16:49:36.864337", "date_withdrawn": null, "embargo_end_date": null, "withdrawal_justification": null, "registration_supplement": "OSF Preregistration", "registered_meta": {"q1": {"extra": [], "value": "Daniel Gibbs"}, "q2": {"extra": [], "value": "Participation in dependency court proceedings will be associated with (1) positive outcomes such as increased engagement and empowerment and (2) negative outcomes such as increased anxiety."}, "q3": {"extra": [], "value": "Meta-Analysis - A systematic review of published studies."}, "q4": {"extra": [], "value": ["No blinding is involved in this study."]}, "q5": {"extra": [], "value": ""}, "q6": {"value": {"question": {"extra": [], "value": "Systematic review (see attached protocol)"}, "uploader": {"extra": [{"data": {"name": "SRProtocol.docx"}, "nodeId": "uj7yx", "sha256": "0ee1725efd44289190c511fd31f3ed9c6abc76b5513a22b0fca9d35bfe9e8245", "viewUrl": "/project/dpgs6/files/osfstorage/5e9dd39243016606d8a06d04/", "selectedFileName": "SRProtocol.docx"}], "value": ""}}}, "q7": {"extra": [], "value": "N/A"}, "q8": {"extra": [], "value": "Registration prior to analysis of the data"}, "q9": {"extra": [], "value": "Comprehensive search and screening methods"}, "q10": {"value": {"question": {"extra": [], "value": "Comprehensive database searches and screening methods (see attached protocol)"}, "uploader": {"extra": [{"data": {"name": "SRProtocol.docx"}, "nodeId": "uj7yx", "sha256": "0ee1725efd44289190c511fd31f3ed9c6abc76b5513a22b0fca9d35bfe9e8245", "viewUrl": "/project/dpgs6/files/osfstorage/5e9dd39243016606d8a06d04/", "selectedFileName": "SRProtocol.docx"}], "value": ""}}}, "q11": {"extra": [], "value": "5-20 studies"}, "q12": {"extra": [], "value": ""}, "q13": {"extra": [], "value": ""}, "q14": {"value": {"question": {"extra": [], "value": ""}, "uploader": {"extra": [], "value": ""}}}, "q15": {"value": {"question": {"extra": [], "value": "Participation or attendance in dependency proceedings\nEffects of participation or attendance in dependency proceedings"}, "uploader": {"extra": [], "value": ""}}}, "q16": {"value": {"question": {"extra": [], "value": ""}, "uploader": {"extra": [], "value": ""}}}, "q17": {"value": {"question": {"extra": [], "value": "Qualitative synthesis of included studies"}, "uploader": {"extra": [], "value": ""}}}, "q18": {"extra": [], "value": ""}, "q19": {"extra": [], "value": ""}, "q20": {"extra": [], "value": ""}, "q21": {"extra": [], "value": ""}, "q22": {"extra": [], "value": ""}, "q23": {"extra": [], "value": ""}}, "registration_responses": {"q1": "Daniel Gibbs", "q2": "Participation in dependency court proceedings will be associated with (1) positive outcomes such as increased engagement and empowerment and (2) negative outcomes such as increased anxiety.", "q3": "Meta-Analysis - A systematic review of published studies.", "q4": ["No blinding is involved in this study."], "q5": "", "q7": "N/A", "q8": "Registration prior to analysis of the data", "q9": "Comprehensive search and screening methods", "q11": "5-20 studies", "q12": "", "q13": "", "q18": "", "q19": "", "q20": "", "q21": "", "q22": "", "q23": "", "q6.question": "Systematic review (see attached protocol)", "q6.uploader": [{"file_id": "5e9dd39243016606d8a06d04", "file_name": "SRProtocol.docx", "file_urls": {"html": "https://osf.io/project/dpgs6/files/osfstorage/5e9dd39243016606d8a06d04", "download": "https://osf.io/download/5e9dd39243016606d8a06d04"}, "file_hashes": {"sha256": "0ee1725efd44289190c511fd31f3ed9c6abc76b5513a22b0fca9d35bfe9e8245"}}], "q10.question": "Comprehensive database searches and screening methods (see attached protocol)", "q10.uploader": [{"file_id": "5e9dd39243016606d8a06d04", "file_name": "SRProtocol.docx", "file_urls": {"html": "https://osf.io/project/dpgs6/files/osfstorage/5e9dd39243016606d8a06d04", "download": "https://osf.io/download/5e9dd39243016606d8a06d04"}, "file_hashes": {"sha256": "0ee1725efd44289190c511fd31f3ed9c6abc76b5513a22b0fca9d35bfe9e8245"}}], "q14.question": "", "q14.uploader": [], "q15.question": "Participation or attendance in dependency proceedings\nEffects of participation or attendance in dependency proceedings", "q15.uploader": [], "q16.question": "", "q16.uploader": [], "q17.question": "Qualitative synthesis of included studies", "q17.uploader": []}, "subjects": [[{"id": "584240db54be81056cecacd3", "text": "Law"}, {"id": "584240da54be81056cecab11", "text": "Courts"}], [{"id": "584240da54be81056cecac48", "text": "Social and Behavioral Sciences"}, {"id": "584240da54be81056cecab71", "text": "Social Work"}], [{"id": "584240db54be81056cecacd3", "text": "Law"}, {"id": "584240d954be81056ceca931", "text": "Family Law"}], [{"id": "584240db54be81056cecacd3", "text": "Law"}, {"id": "584240da54be81056cecabd0", "text": "Juvenile Law"}]]}, "relationships": {"license": {"links": {"related": {"href": "https://api.osf.io/v2/licenses/563c1cf88c5e4a3877f9e965/?format=json", "meta": {}}}, "data": {"id": "563c1cf88c5e4a3877f9e965", "type": "licenses"}}, "children": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/dpgs6/children/?format=json", "meta": {}}}}, "comments": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/dpgs6/comments/?format=json&filter%5Btarget%5D=dpgs6", "meta": {}}}}, "contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/dpgs6/contributors/?format=json", "meta": {}}}}, "bibliographic_contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/dpgs6/bibliographic_contributors/?format=json", "meta": {}}}}, "implicit_contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/dpgs6/implicit_contributors/?format=json", "meta": {}}}}, "files": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/dpgs6/files/?format=json", "meta": {}}}}, "wikis": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/dpgs6/wikis/?format=json", "meta": {}}}}, "forks": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/dpgs6/forks/?format=json", "meta": {}}}}, "node_links": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/dpgs6/node_links/?format=json", "meta": {}}}}, "linked_by_nodes": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/dpgs6/linked_by_nodes/?format=json", "meta": {}}}}, "linked_by_registrations": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/dpgs6/linked_by_registrations/?format=json", "meta": {}}}}, "identifiers": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/dpgs6/identifiers/?format=json", "meta": {}}}}, "affiliated_institutions": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/dpgs6/institutions/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/dpgs6/relationships/institutions/?format=json", "meta": {}}}}, "region": {"links": {"related": {"href": "https://api.osf.io/v2/regions/us/?format=json", "meta": {}}}, "data": {"id": "us", "type": "regions"}}, "root": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/dpgs6/?format=json", "meta": {}}}, "data": {"id": "dpgs6", "type": "registrations"}}, "logs": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/dpgs6/logs/?format=json", "meta": {}}}}, "linked_nodes": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/dpgs6/linked_nodes/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/dpgs6/relationships/linked_nodes/?format=json", "meta": {}}}}, "linked_registrations": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/dpgs6/linked_registrations/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/dpgs6/relationships/linked_registrations/?format=json", "meta": {}}}}, "view_only_links": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/dpgs6/view_only_links/?format=json", "meta": {}}}}, "citation": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/dpgs6/citation/?format=json", "meta": {}}}, "data": {"id": "dpgs6", "type": "registrations"}}, "registered_by": {"links": {"related": {"href": "https://api.osf.io/v2/users/he3gv/?format=json", "meta": {}}}, "data": {"id": "he3gv", "type": "users"}}, "registered_from": {"links": {"related": {"href": "https://api.osf.io/v2/nodes/uj7yx/?format=json", "meta": {}}}, "data": {"id": "uj7yx", "type": "nodes"}}, "registration_schema": {"links": {"related": {"href": "https://api.osf.io/v2/schemas/registrations/5e795fc0d2833800195735d0/?format=json", "meta": {}}}, "data": {"id": "5e795fc0d2833800195735d0", "type": "registration-schemas"}}, "provider": {"links": {"related": {"href": "https://api.osf.io/v2/providers/registrations/osf/?format=json", "meta": {}}}}}, "links": {"html": "https://osf.io/dpgs6/", "self": "https://api.osf.io/v2/registrations/dpgs6/"}}, {"id": "4mwjs", "type": "registrations", "attributes": {"title": "Prior Selection", "description": "", "category": "", "custom_citation": "", "date_created": "2020-04-20T16:13:37.588714", "date_modified": "2020-04-20T15:59:03.090264", "registration": true, "preprint": false, "fork": false, "collection": false, "tags": [], "access_requests_enabled": false, "node_license": {"copyright_holders": [""], "year": "2020"}, "analytics_key": "3ea0b4b3ae45d66a3c785bee90c6f7896818c1aaa368f4d86e2f492502bf4d523b944053eab7231c34a4eb8738c1d4b6791604bb695be66310af84d2520755747db25106a5124d8be892499991822dd909ebaa303eb4d1de6667237644583fb9f912d0632b27efdffa717afd8d92b09fe665bea7388f9ee5f66a2cc84f03013fb2cb75f92dccbb8579dd8d75b7bdbe69", "current_user_can_comment": false, "current_user_permissions": ["read"], "current_user_is_contributor": false, "current_user_is_contributor_or_group_member": false, "wiki_enabled": true, "public": true, "article_doi": null, "pending_embargo_approval": false, "pending_embargo_termination_approval": false, "embargoed": false, "pending_registration_approval": false, "archiving": false, "pending_withdrawal": false, "withdrawn": false, "date_registered": "2020-04-20T16:13:37.573233", "date_withdrawn": null, "embargo_end_date": null, "withdrawal_justification": null, "registration_supplement": "Open-Ended Registration", "registered_meta": {"summary": {"extra": [], "value": "The research aims, analysis plan and priors for this study were selected before data analysis. Details of these are available in the pre-analysis protocol and prior selection document."}, "uploader": {"extra": [{"data": {"name": "Prior predictive simulation_usage and purchase of e-cigarette device types.pdf"}, "nodeId": "57fvd", "sha256": "f7878f416a86e50b7e9c072c7be62656047acc95ca155c990292a8b078cab67c", "viewUrl": "/project/57fvd/files/osfstorage/5e9dc90ad6973506b5bdc01e", "selectedFileName": "Prior predictive simulation_usage and purchase of e-cigarette device types.pdf"}, {"data": {"name": "Trends in the usage and purchase of e-cigarettes_pre-analysis_protocol.pdf"}, "nodeId": "57fvd", "sha256": "649945322fd787e42f33403a14008b62b19a5e82059b1870f060ad64b8dbf2eb", "viewUrl": "/project/57fvd/files/osfstorage/5e9dc918d6973506bbbdb58e", "selectedFileName": "Trends in the usage and purchase of e-cigarettes_pre-analysis_protocol.pdf"}], "value": ""}}, "registration_responses": {"summary": "The research aims, analysis plan and priors for this study were selected before data analysis. Details of these are available in the pre-analysis protocol and prior selection document.", "uploader": [{"file_id": "5e9dc90ad6973506b5bdc01e", "file_name": "Prior predictive simulation_usage and purchase of e-cigarette device types.pdf", "file_urls": {"html": "https://osf.io/57fvd/files/osfstorage/5e9dc90ad6973506b5bdc01e", "download": "https://osf.io/download/kx3h4/"}, "file_hashes": {"sha256": "f7878f416a86e50b7e9c072c7be62656047acc95ca155c990292a8b078cab67c"}}, {"file_id": "5e9dc918d6973506bbbdb58e", "file_name": "Trends in the usage and purchase of e-cigarettes_pre-analysis_protocol.pdf", "file_urls": {"html": "https://osf.io/57fvd/files/osfstorage/5e9dc918d6973506bbbdb58e", "download": "https://osf.io/download/6s8vu/"}, "file_hashes": {"sha256": "649945322fd787e42f33403a14008b62b19a5e82059b1870f060ad64b8dbf2eb"}}]}, "subjects": []}, "relationships": {"license": {"links": {"related": {"href": "https://api.osf.io/v2/licenses/563c1cf88c5e4a3877f9e96a/?format=json", "meta": {}}}, "data": {"id": "563c1cf88c5e4a3877f9e96a", "type": "licenses"}}, "children": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/4mwjs/children/?format=json", "meta": {}}}}, "comments": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/4mwjs/comments/?format=json&filter%5Btarget%5D=4mwjs", "meta": {}}}}, "contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/4mwjs/contributors/?format=json", "meta": {}}}}, "bibliographic_contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/4mwjs/bibliographic_contributors/?format=json", "meta": {}}}}, "implicit_contributors": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/4mwjs/implicit_contributors/?format=json", "meta": {}}}}, "files": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/4mwjs/files/?format=json", "meta": {}}}}, "wikis": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/4mwjs/wikis/?format=json", "meta": {}}}}, "forks": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/4mwjs/forks/?format=json", "meta": {}}}}, "node_links": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/4mwjs/node_links/?format=json", "meta": {}}}}, "linked_by_nodes": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/4mwjs/linked_by_nodes/?format=json", "meta": {}}}}, "linked_by_registrations": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/4mwjs/linked_by_registrations/?format=json", "meta": {}}}}, "parent": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/9ep6h/?format=json", "meta": {}}}, "data": {"id": "9ep6h", "type": "registrations"}}, "identifiers": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/4mwjs/identifiers/?format=json", "meta": {}}}}, "affiliated_institutions": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/4mwjs/institutions/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/4mwjs/relationships/institutions/?format=json", "meta": {}}}}, "region": {"links": {"related": {"href": "https://api.osf.io/v2/regions/de-1/?format=json", "meta": {}}}, "data": {"id": "de-1", "type": "regions"}}, "root": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/9ep6h/?format=json", "meta": {}}}, "data": {"id": "9ep6h", "type": "registrations"}}, "logs": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/4mwjs/logs/?format=json", "meta": {}}}}, "linked_nodes": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/4mwjs/linked_nodes/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/4mwjs/relationships/linked_nodes/?format=json", "meta": {}}}}, "linked_registrations": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/4mwjs/linked_registrations/?format=json", "meta": {}}, "self": {"href": "https://api.osf.io/v2/registrations/4mwjs/relationships/linked_registrations/?format=json", "meta": {}}}}, "view_only_links": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/4mwjs/view_only_links/?format=json", "meta": {}}}}, "citation": {"links": {"related": {"href": "https://api.osf.io/v2/registrations/4mwjs/citation/?format=json", "meta": {}}}, "data": {"id": "4mwjs", "type": "registrations"}}, "registered_by": {"links": {"related": {"href": "https://api.osf.io/v2/users/9v4rz/?format=json", "meta": {}}}, "data": {"id": "9v4rz", "type": "users"}}, "registered_from": {"links": {"related": {"href": "https://api.osf.io/v2/nodes/r8fh7/?format=json", "meta": {}}}, "data": {"id": "r8fh7", "type": "nodes"}}, "registration_schema": {"links": {"related": {"href": "https://api.osf.io/v2/schemas/registrations/5df83f7dd28338001ac0ab0d/?format=json", "meta": {}}}, "data": {"id": "5df83f7dd28338001ac0ab0d", "type": "registration-schemas"}}, "provider": {"links": {"related": {"href": "https://api.osf.io/v2/providers/registrations/osf/?format=json", "meta": {}}}}}, "links": {"html": "https://osf.io/4mwjs/", "self": "https://api.osf.io/v2/registrations/4mwjs/"}}], "links": {"first": "https://api.osf.io/v2/registrations/?filter%5Bdate_created%5D%5Bgt%5D=2019-12-31&format=json", "last": "https://api.osf.io/v2/registrations/?filter%5Bdate_created%5D%5Bgt%5D=2019-12-31&format=json&page=547", "prev": "https://api.osf.io/v2/registrations/?filter%5Bdate_created%5D%5Bgt%5D=2019-12-31&format=json&page=13", "next": "https://api.osf.io/v2/registrations/?filter%5Bdate_created%5D%5Bgt%5D=2019-12-31&format=json&page=15", "meta": {"total": 5469, "per_page": 10}}}